Datasets:
oliverwang15
/
us_stock_news_with_price

Dataset card Viewer Files Community
1
date
date32
stock
stringclasses
98 values
title
stringlengths
13
158
content
stringlengths
2
15k
trading_date
timestamp[ns]
exact_trading_date
timestamp[ns]
ts_-30
float64
0.23
2.5k
ts_-29
float64
0.22
2.62k
ts_-28
float64
0.22
2.64k
ts_-27
float64
0.23
2.65k
ts_-26
float64
0.23
2.65k
ts_-25
float64
0.23
2.57k
ts_-24
float64
0.23
2.48k
ts_-23
float64
0.25
2.48k
ts_-22
float64
0.25
2.51k
ts_-21
float64
0.25
2.62k
ts_-20
float64
0.24
2.64k
ts_-19
float64
0.25
2.65k
ts_-18
float64
0.25
2.62k
ts_-17
float64
0.25
2.64k
ts_-16
float64
0.24
2.65k
ts_-15
float64
0.23
2.64k
ts_-14
float64
0.24
2.65k
ts_-13
float64
0.24
2.62k
ts_-12
float64
0.23
2.64k
ts_-11
float64
0.23
2.65k
ts_-10
float64
0.23
2.57k
ts_-9
float64
0.22
2.48k
ts_-8
float64
0.22
2.49k
ts_-7
float64
0.23
2.48k
ts_-6
float64
0.24
2.51k
ts_-5
float64
0.23
2.51k
ts_-4
float64
0.23
2.62k
ts_-3
float64
0.22
2.64k
ts_-2
float64
0.22
2.65k
ts_-1
float64
0.22
2.57k
ts_0
float64
0.23
2.48k
ts_1
float64
0.23
2.62k
ts_2
float64
0.23
2.64k
ts_3
float64
0.23
2.65k
ts_4
float64
0.22
2.65k
ts_5
float64
0.22
2.57k
ts_6
float64
0.23
2.48k
ts_7
float64
0.23
2.46k
ts_8
float64
0.23
2.5k
ts_9
float64
0.23
2.54k
ts_10
float64
0.23
2.51k
ts_11
float64
0.22
2.5k
ts_12
float64
0.22
2.48k
ts_13
float64
0.23
2.44k
ts_14
float64
0.23
2.48k
ts_15
float64
0.23
2.46k
2019-09-23
WBA
Synchrony's CareCredit expands to Walgreens, Duane Reade stores
Synchrony Financial's (NYSE:SYF) CareCredit network expands to include more than 8,500 Walgreens (NASDAQ:WBA) and Duane Reade stores in the U.S., Puerto Rico, and Virgin Islands. CareCredit allows consumers to pay over time for deductibles, co-pays, co-insurance, and out-of-pocket medical expenses like prescriptions.  CareCredit generally enables providers to receive payment for services within two business days of accepting the card for payment, with no financial liability to the provider if the patient delays or defaults on payment.
2019-09-24T00:00:00
2019-09-24T00:00:00
52
53.07
50.41
49.290001
50.48
51.16
50.669998
50.900002
50.950001
49.32
50.040001
49.450001
49.950001
50.400002
51.189999
50.43
51.43
52.330002
52.560001
55.59
56.880001
58.060001
55.560001
55.990002
55.34
54.84
54.41
54.57
55
54.32
53.630001
54.360001
54.080002
54.41
55.310001
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
2019-09-27
WBA
Goldman sees 38% upside in Seattle Genetics in premarket analyst action
Arcus Biosciences (NYSE:RCUS) initiated with Buy rating and $22 (150% upside) price target at Mizuho Securities. Stealth BioTherapeutics (NASDAQ:MITO) initiated with Overweight rating at Cantor Fitzgerald. Hookipa Pharma (NASDAQ:HOOK) initiated with Buy rating and $15 (93% upside) price target at H.C. Wainwright. Argenx (NASDAQ:ARGX) initiated with Market Perform rating and $125 (8% upside) price target at Wells Fargo citing valuation. CVS Health (NYSE:CVS) resumed with Outperform rating and $85 (39% upside) price target at RBC Capital Markets. Walgreens Boots Alliance (NASDAQ:WBA) resumed with Sector Perform rating and $59 (9% upside) price target at RBC. Applied Genetic Technologies (NASDAQ:AGTC) upgraded to Outperform with a $9 (125% upside) price target at BMO. Shares up 14% premarket. Seattle Genetics (NASDAQ:SGEN) upgraded to Buy with a $100 (38% upside) price target at Goldman Sachs. Accelerate Diagnostics (NASDAQ:AXDX) downgraded to Underweight with a $16 (22% downside risk) price target at JPMorgan. Atara Biotherapeutics (NASDAQ:ATRA) downgraded to Sell with a $9 (34% downside risk) price target at Goldman. Luminex (NASDAQ:LMNX) downgraded to Underweight with a $21 (3% downside risk) price target at JPMorgan. Shares down 4% premarket.
2019-09-28T00:00:00
2019-09-30T00:00:00
50.48
51.16
50.669998
50.900002
50.950001
49.32
50.040001
49.450001
49.950001
50.400002
51.189999
50.43
51.43
52.330002
52.560001
55.59
56.880001
58.060001
55.560001
55.990002
55.34
54.84
54.41
54.57
55
54.32
53.630001
54.360001
54.080002
54.41
55.310001
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
2019-10-01
WBA
Three pharmacies now pulling Zantac over FDA alert
Three major pharmacies are now pulling Sanofi's (NASDAQ:SNY) heartburn medication Zantac off the shelves, after an FDA alert about potential low levels of a probable human carcinogen. CVS (NYSE:CVS) had previously pulled the drug, and Walgreens (NASDAQ:WBA) and Rite Aid (NYSE:RAD) have joined in by removing the medication. The FDA has said some ranitidine medicines including Zantac contain NDMA at low levels (levels that barely exceed amounts you might expected to find in common foods, it says). There's no recall of the medication, but all three pharmacies are accepting it for returns.
2019-10-02T00:00:00
2019-10-02T00:00:00
50.669998
50.900002
50.950001
49.32
50.040001
49.450001
49.950001
50.400002
51.189999
50.43
51.43
52.330002
52.560001
55.59
56.880001
58.060001
55.560001
55.990002
55.34
54.84
54.41
54.57
55
54.32
53.630001
54.360001
54.080002
54.41
55.310001
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
55.32
54.560001
2019-10-02
WBA
Postmates comes to select Walgreens stores
DoorDash (DOORD) and Postmates (POSTM) are among the food delivery companies branching out in an increasingly competitive market. Today, Postmates announced it would start deliveries from 174 Walgreens (NASDAQ:WBA) and Duane Reade stores in Manhattan and Brooklyn. Postmates hopes to strike a nationwide deal with Walgreens. Postmates also delivers from 7-Eleven stores and Walmart. DoorDash delivers from Walmart and recently signed an agreement with Mercato to deliver from 750 independent grocers in 22 states. Uber (NYSE:UBER) Eats is testing grocery delivery in Australia and is in similar talks in Europe and North America.
2019-10-03T00:00:00
2019-10-03T00:00:00
50.900002
50.950001
49.32
50.040001
49.450001
49.950001
50.400002
51.189999
50.43
51.43
52.330002
52.560001
55.59
56.880001
58.060001
55.560001
55.990002
55.34
54.84
54.41
54.57
55
54.32
53.630001
54.360001
54.080002
54.41
55.310001
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
55.32
54.560001
54.450001
2019-10-01
WBA
J&J agrees to settlement with two Ohio counties ahead of opioid trial
Johnson & Johnson (NYSE:JNJ) says it will pay a $20.4M settlement with Cuyahoga and Summit counties in Ohio that accused it of contributing to the U.S. opioid addiction epidemic. JNJ says the deal resolves all of the counties' claims with no admission of liability and removes the company from a federal trial scheduled to begin Oct. 21. Yesterday, Mallinckrodt (NYSE:MNK) announced a $24M settlement with the same two counties, and Endo International (NASDAQ:ENDP) and Allergan (NYSE:AGN) had settled with the counties in August to avoid going to trial. Remaining defendants in the Oct. 21 trial include McKesson (NYSE:MCK), AmerisourceBergen (NYSE:ABC), Cardinal Health (NYSE:CAH), Teva Pharmaceutical (NYSE:TEVA), Walgreens Boots Alliance (NASDAQ:WBA) and Henry Schein (NASDAQ:HSIC). JNJ and most of the other companies still face thousands of lawsuits related to the opioid epidemic.
2019-10-02T00:00:00
2019-10-02T00:00:00
50.669998
50.900002
50.950001
49.32
50.040001
49.450001
49.950001
50.400002
51.189999
50.43
51.43
52.330002
52.560001
55.59
56.880001
58.060001
55.560001
55.990002
55.34
54.84
54.41
54.57
55
54.32
53.630001
54.360001
54.080002
54.41
55.310001
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
55.32
54.560001
2019-10-17
WBA
Centene and Walgreens team up with RxAdvance in pharmacy management
Centene (NYSE:CNC), Walgreens (NASDAQ:WBA) and RxAdvance have agreed to partner on introducing a new model for pharmacy management aimed at improved transparency, an enhanced customer experience and better health outcomes at lower costs. The partnership will leverage RxAdance's Collaborative PBM Cloud transactional platform and clinical intelligence with Walgreens' retail pharmacy knowhow and Centene's leadership in delivering comprehensive healthcare services to the underserved. Centene has increased its ownership stake in RxAdance while Walgreens has made a "small" investment. Specific financial terms are not disclosed.
2019-10-18T00:00:00
2019-10-18T00:00:00
52.560001
55.59
56.880001
58.060001
55.560001
55.990002
55.34
54.84
54.41
54.57
55
54.32
53.630001
54.360001
54.080002
54.41
55.310001
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
55.32
54.560001
54.450001
55.419998
55.799999
56.27
55.860001
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
2019-10-18
WBA
Huge opioid settlement hits late snag
The first federal case in the opioid crisis seems headed to trial Monday after an 11th-hour settlement appeared to be breaking down. A $50B bid from four state AGs and corporate executives to settle hundreds of lawsuits and head off the federal trial faced opposition from local officials. There's been no progress in getting three distributors -- McKesson (NYSE:MCK), Cardinal Health (NYSE:CAH) and AmerisourceBergen (NYSE:ABC) -- to boost a settlement offer from $18B over 18 years, according to the lead attorney for 2,400 cities and counties. And Teva (NYSE:TEVA) isn't budging from its offer of a few hundred million dollars plus anti-addiction drugs, and there's been little negotiation with Walgreens (NASDAQ:WBA), he says. Johnson & Johnson (NYSE:JNJ) has agreed to contribute $4B over a shorter time frame. After hours: MCK -3.1%; CAH -3%; ABC -1.8%; WBA -0.4%; JNJ +0.1%; ENDP -2.4%; TEVA -1.6%.
2019-10-19T00:00:00
2019-10-21T00:00:00
55.59
56.880001
58.060001
55.560001
55.990002
55.34
54.84
54.41
54.57
55
54.32
53.630001
54.360001
54.080002
54.41
55.310001
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
55.32
54.560001
54.450001
55.419998
55.799999
56.27
55.860001
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
62.25
2019-10-21
WBA
Opioid defendants reach settlement to avoid trial
The WSJ reports that Teva Pharmaceutical Industries (NYSE:TEVA), McKesson (NYSE:MCK), AmerisourceBergen (NYSE:ABC) and Cardinal Health (NYSE:CAH) have reached a last-minute settlement with two Ohio counties over their alleged role in the opioid crisis there. The settlement will enable the companies to avoid a trial in Cleveland that was to start today. The news should reverse the premarket selloff, assuming a reasonable settlement that is. A fifth defendant, Walgreens Boots Alliance (NASDAQ:WBA), has not settled yet. Update: According to the Washington Post, the settlement is valued at $260M. A broader settlement aimed at resolving thousands of outstanding lawsuits from states and local governments has not been reached. Medical products distributor Henry Schein (NASDAQ:HSIC) agreed to pay $1.25M to settle ($1M to establish an educational foundation in Summit County and $0.25M for Summit County expenses). It is unclear whether the trial will commence with only one defendant (WBA) left. Update: The three wholesalers agreed to pay $215M to the two counties.
2019-10-22T00:00:00
2019-10-22T00:00:00
56.880001
58.060001
55.560001
55.990002
55.34
54.84
54.41
54.57
55
54.32
53.630001
54.360001
54.080002
54.41
55.310001
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
55.32
54.560001
54.450001
55.419998
55.799999
56.27
55.860001
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
62.25
62.720001
2019-10-20
WBA
Four players in opioid epidemic face trial in Ohio Monday
Barring a last-minute settlement agreement, lawyers representing drugmaker Teva Pharmaceutical Industries, wholesalers Cardinal Health and AmerisourceBergen and retail pharmacy operator Walgreens Boots Alliance will be in a Cleveland, Ohio courtroom on Monday to face plaintiffs, two counties in the state (Cuyahoga and Summit), in a trial over the companies' respective roles in the opioid epidemic there (mainly over-aggressive marketing while downplaying the risk of addiction). Apparently, the companies had agreed to pay as much as $48B over time to call off the trial and settle thousands of related lawsuits but talks stalled when contingency-fee lawyers representing local governments insisted on more money. District court Judge Dan Polster has set aside December 13 for evidence to be presented to the jury. Each side has 100 hours do state their respective cases, which some of the defendants say is woefully inadequate to argue a case of this complexity. Private held Purdue Pharma, the poster child for the crisis, will not be present since it filed for bankruptcy last month.
2019-10-21T00:00:00
2019-10-21T00:00:00
55.59
56.880001
58.060001
55.560001
55.990002
55.34
54.84
54.41
54.57
55
54.32
53.630001
54.360001
54.080002
54.41
55.310001
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
55.32
54.560001
54.450001
55.419998
55.799999
56.27
55.860001
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
62.25
2019-10-23
WBA
Sell-siders upgrade Biogen on aducanumab prospects, Raymond James doubts
DexCom (NASDAQ:DXCM) initiated with Buy rating and $190 (26% upside) price target at Stifel. Insulet (NASDAQ:PODD) initiated with Hold rating and $163 (8% upside) price target at Stifel. Senseonics (NYSEMKT:SENS) initiated with Buy rating and $2 (111% upside) price target at Stifel. Biogen (NASDAQ:BIIB) upgraded to Buy with a $365 (29% upside) price target at Guggenheim. Upgraded to Outperform with a $350 price target at SVB Leerink on the news that it plans to file a U.S. marketing for Alzheimer's med aducanumab. Raymond James is not on board, though, saying that the FDA will give the application the thumbs down. Shares up 2% premarket. Walgreens Boots Alliance (NASDAQ:WBA) downgraded to Neutral with a $63 (14% upside) price target at JPMorgan. Shares down 1% premarket.
2019-10-24T00:00:00
2019-10-24T00:00:00
55.560001
55.990002
55.34
54.84
54.41
54.57
55
54.32
53.630001
54.360001
54.080002
54.41
55.310001
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
55.32
54.560001
54.450001
55.419998
55.799999
56.27
55.860001
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
62.25
62.720001
62.25
61.939999
2019-10-23
WBA
Walgreens Boots declares $0.4575 dividend
Walgreens Boots (NASDAQ:WBA) declares $0.4575/share quarterly dividend, in line with previous. Forward yield 3.36% Payable Dec. 12; for shareholders of record Nov. 18; ex-div Nov. 15. See WBA Dividend Scorecard, Yield Chart, & Dividend Growth.
2019-10-24T00:00:00
2019-10-24T00:00:00
55.560001
55.990002
55.34
54.84
54.41
54.57
55
54.32
53.630001
54.360001
54.080002
54.41
55.310001
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
55.32
54.560001
54.450001
55.419998
55.799999
56.27
55.860001
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
62.25
62.720001
62.25
61.939999
2019-10-28
WBA
Walgreens Boots Alliance up 2% premarket on FQ4 beat
Walgreens Boots Alliance (NASDAQ:WBA) fiscal Q4 results: Total sales: $33,954M (+1.5%). Retail Pharmacy USA sales: $26,040M (+2.1%). Organic sales growth was 2.9%. Pharmacy Wholesale revenue was up 3.1% to $5,742M. Net income: $686M (-54.7%); non-GAAP net income: $1,284 (-11.3%); EPS: $0.75 (-51.6%); non-GAAP EPS: 1.43 (-3.4%). FY cash flow ops: $5,594M (-32.3%); FQ4 cash flow ops: $2,378M (-15.6%). Fiscal 2020 guidance: Essentially flat growth in non-GAAP EPS (range: +-3%). Shares up 2% premarket on light volume. Previously: Walgreens Boots EPS beats by $0.02, beats on revenue (Oct. 28)
2019-10-29T00:00:00
2019-10-29T00:00:00
54.84
54.41
54.57
55
54.32
53.630001
54.360001
54.080002
54.41
55.310001
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
55.32
54.560001
54.450001
55.419998
55.799999
56.27
55.860001
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
62.25
62.720001
62.25
61.939999
62.139999
61.939999
61.450001
2019-10-28
WBA
Walgreens Boots EPS beats by $0.02, beats on revenue
Walgreens Boots (NASDAQ:WBA): Q4 Non-GAAP EPS of $1.43 beats by $0.02; GAAP EPS of $0.75 misses by $0.46. Revenue of $33.95B (+1.5% Y/Y) beats by $70M. Press Release
2019-10-29T00:00:00
2019-10-29T00:00:00
54.84
54.41
54.57
55
54.32
53.630001
54.360001
54.080002
54.41
55.310001
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
55.32
54.560001
54.450001
55.419998
55.799999
56.27
55.860001
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
62.25
62.720001
62.25
61.939999
62.139999
61.939999
61.450001
2019-10-27
WBA
Walgreens Boots Q4 2019 Earnings Preview
Walgreens Boots (NASDAQ:WBA) is scheduled to announce Q4 earnings results on Monday, October 28th, before market open. The consensus EPS Estimate is $1.41 (-4.7% Y/Y) and the consensus Revenue Estimate is $33.88B (+1.3% Y/Y). Over the last 2 years, wba has beaten EPS estimates 88% of the time and has beaten revenue estimates 63% of the time. Over the last 3 months, EPS estimates have seen 3 upward revisions and 5 downward. Revenue estimates have seen 2 upward revisions and 4 downward.
2019-10-28T00:00:00
2019-10-28T00:00:00
55.34
54.84
54.41
54.57
55
54.32
53.630001
54.360001
54.080002
54.41
55.310001
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
55.32
54.560001
54.450001
55.419998
55.799999
56.27
55.860001
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
62.25
62.720001
62.25
61.939999
62.139999
61.939999
2019-11-06
WBA
Analysts handicap Walgreens buyout
Walgreens Boots Alliance (WBA -2.8%) slips below $60 the day after the blockbuster news that the company is mulling over a PE-backed leveraged buyout. Analysts are still buzzing over the M&A wildcard. This morning, Jefferies calls the odds of a takeout low and Wells Fargo places the probability of a deal below 50%. Meanwhile, Mizuho thinks any buyout deal would land in the $60 to $67 range. Even at that level, a LBO would be among the largest in history, although shares of Walgreen were swapping hands as high as $86 late last year. Other analysts see the LBO exploration as a possible precursor to asset sales by Walgreens or cost-cutting initiatives.
2019-11-07T00:00:00
2019-11-07T00:00:00
54.080002
54.41
55.310001
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
55.32
54.560001
54.450001
55.419998
55.799999
56.27
55.860001
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
62.25
62.720001
62.25
61.939999
62.139999
61.939999
61.450001
61.34
60.619999
60.599998
60.669998
59.630001
60.110001
59.599998
2019-11-05
WBA
Walgreens brings in powerhouse PE firms for talks
Walgreens Boots Alliance (WBA +3.9%) has been in talks with large private equity firms about the potential of stitching together a huge leveraged buyout of the retail chain, sources tell Reuters. Evercore Partners is working with Walgreens on the exploratory process. If a deal was struck, it would likely be one of the largest leveraged buyouts in history based off Walgreens +$50B market cap. Walgreens hasn't issued a comment on the report. Volume on Walgreens is over 4X normal activity with two hours of trading to go. Previously: Walgreens spikes on report of go-private interest (Nov. 5)
2019-11-06T00:00:00
2019-11-06T00:00:00
54.360001
54.080002
54.41
55.310001
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
55.32
54.560001
54.450001
55.419998
55.799999
56.27
55.860001
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
62.25
62.720001
62.25
61.939999
62.139999
61.939999
61.450001
61.34
60.619999
60.599998
60.669998
59.630001
60.110001
2019-11-05
WBA
Walgreens spikes on report of go-private interest
Trading on Walgreens Boots Alliance (WBA +5.4%) has been halted due to a volatility spike following a Reuters report indicating the company is exploring a potential go-private deal.
2019-11-06T00:00:00
2019-11-06T00:00:00
54.360001
54.080002
54.41
55.310001
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
55.32
54.560001
54.450001
55.419998
55.799999
56.27
55.860001
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
62.25
62.720001
62.25
61.939999
62.139999
61.939999
61.450001
61.34
60.619999
60.599998
60.669998
59.630001
60.110001
2019-11-11
WBA
Walgreens Boots Alliance gains on KKR interest
Walgreens Boots Alliance (NASDAQ:WBA) is up 8% premarket on modest volume in apparent reaction to a report that KKR (NYSE:KKR) has approached it about a buyout. Shares rallied last week over reports that private-equity shops were circling. Update: Bloomberg reports that KKR is preparing a proposal to take WBA private, although no final decisions have been made.
2019-11-12T00:00:00
2019-11-12T00:00:00
54.700001
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
55.32
54.560001
54.450001
55.419998
55.799999
56.27
55.860001
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
62.25
62.720001
62.25
61.939999
62.139999
61.939999
61.450001
61.34
60.619999
60.599998
60.669998
59.630001
60.110001
59.599998
59.27
58.990002
58.91
2019-11-12
WBA
JPMorgan puts a number to a Walgreens buyout
JPMorgan crunches the numbers on what a leveraged buyout of Walgreen Boots Alliance (WBA +0.5%) would look like. "We believe a potential deal could be valued at up to ~$75 per WBA share, based on our assumptions around maximum lease-adjusted leverage and minimum IRR to private equity owners. We assume a maximum lease-adjusted leverage ratio immediately post the deal close of 6.5x (what the company could potentially support based on our discussions with our JPM credit counterparts). Further, we also assume private equity owners would require a minimum IRR of 15% over a five-year period. We also assume an exit multiple of 10.0x forward EBITDA after five years. Using those parameters, we believe that could imply a maximum transaction value of ~$85 billion, which would imply an equity value of ~$74.97 per share (or a ~20% premium to yesterday’s closing price)." The firm sees some uncertainties that could impact a potential Walgreens deal - including exposure to opioid settlements, Brexit and the political/regulatory environment in the U.S. It's also unclear if private equity could raise the ~$22B needed based off the JP analysis.
2019-11-13T00:00:00
2019-11-13T00:00:00
52.830002
52.599998
52.970001
52.759998
52.09
52.080002
52.93
53.990002
53.669998
54.52
54.66
55.939999
55.299999
54.59
55.32
54.560001
54.450001
55.419998
55.799999
56.27
55.860001
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
62.25
62.720001
62.25
61.939999
62.139999
61.939999
61.450001
61.34
60.619999
60.599998
60.669998
59.630001
60.110001
59.599998
59.27
58.990002
58.91
59.099998
2019-12-02
WBA
Walgreens buyout stalls as expected
The private equity buyout of Walgreens Boots Alliance (NASDAQ:WBA) is reportedly in trouble as financing issue arise for KKR (NYSE:KKR) just as many analysts anticipated. Speed bumps with leveraged buyouts are nothing new this year, according to The Wall Street Journal. Buyout activity in the U.S. is down sharply, despite PE firms sitting on a record amount of cash. WBA -0.35% premarket to $59.60.
2019-12-03T00:00:00
2019-12-03T00:00:00
54.59
55.32
54.560001
54.450001
55.419998
55.799999
56.27
55.860001
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
62.25
62.720001
62.25
61.939999
62.139999
61.939999
61.450001
61.34
60.619999
60.599998
60.669998
59.630001
60.110001
59.599998
59.27
58.990002
58.91
59.099998
58.630001
58.709999
58.41
58.009998
58.580002
57.880001
57.799999
57.09
57.200001
57.75
58.389999
58.57
58.349998
2019-12-11
WBA
Kroger and Walgreens deepen ties
Kroger (KR -0.4%) and Walgreens Boots Alliance (WBA -0.7%) are in what they call a Retail Procurement Alliance to cut down on merchandise costs. Essentially, the two retail giants plan to order some products together in categories that they overlap. Kroger and Walgreens hope more retailers will join the alliance. Walgreens is also looking at adding more food products from Kroger's pantry of in-house brands.
2019-12-12T00:00:00
2019-12-12T00:00:00
55.860001
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
62.25
62.720001
62.25
61.939999
62.139999
61.939999
61.450001
61.34
60.619999
60.599998
60.669998
59.630001
60.110001
59.599998
59.27
58.990002
58.91
59.099998
58.630001
58.709999
58.41
58.009998
58.580002
57.880001
57.799999
57.09
57.200001
57.75
58.389999
58.57
58.349998
58.900002
59.02
58.91
58.959999
59.080002
59.080002
59.59
2019-12-11
WBA
Wells cuts view on Cigna in premarket analyst action
AdaptHealth (NASDAQ:AHCO) initiated with Outperform rating and $13 (30% upside) price target at SVB Leerink. Cyclo Therapeutics (OTCQB:CTDH) initiated with Buy rating and $1.25 (400% upside) price target at ThinkEquity. CryoLife (NYSE:CRY) upgraded to Buy at Needham. Shares up 2% premarket. Acadia Healthcare (NASDAQ:ACHC) downgraded to Equal Weight with a $35 (9% upside) price target at Wells Fargo. Cigna (NYSE:CI) downgraded to Underweight with a $181 (6% downside risk) price target at Wells Fargo. Correvio Pharma (NASDAQ:CORV) downgraded to Sell at Bloom Burton & Co. Shares down 59% premarket after negative FDA advisory committee vote on Brinavess for AF. DENTSPLY SIRONA (NASDAQ:XRAY) downgraded to Neutral with a $65 (13% upside) price target at JPMorgan. Shares down 2% premarket. Encompass Health (NYSE:EHC) downgraded to Underweight with a $68 (5% downside risk) price target at Wells Fargo. GenMark Diagnostics (NASDAQ:GNMK) downgraded to Neutral with a $7 (25% upside) price target at JPMorgan. Iterum Therapeutics (NASDAQ:ITRM) downgraded to Market Perform with a $4 (18% downside risk) price target at SVB Leerink. Shares down 47% premarket after failed Phase 3 study of sulopenem. Lexicon Pharmaceuticals (NASDAQ:LXRX) downgraded to Hold at Gabelli & Co. Shares down 2% premarket. Surmodics (NASDAQ:SRDX) downgraded to Hold at Needham. Shares down 2% premarket. Walgreens Boots Alliance (NASDAQ:WBA) downgraded to Equal Weight with a $61 (4% upside) price target at Wells Fargo. Shares down 1% premarket. WellCare Health Plans (NYSE:WCG) downgraded to Equal Weight with a $342 (7% upside) price target at Wells Fargo.
2019-12-12T00:00:00
2019-12-12T00:00:00
55.860001
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
62.25
62.720001
62.25
61.939999
62.139999
61.939999
61.450001
61.34
60.619999
60.599998
60.669998
59.630001
60.110001
59.599998
59.27
58.990002
58.91
59.099998
58.630001
58.709999
58.41
58.009998
58.580002
57.880001
57.799999
57.09
57.200001
57.75
58.389999
58.57
58.349998
58.900002
59.02
58.91
58.959999
59.080002
59.080002
59.59
2019-12-12
WBA
Walgreens Boots Alliance and McKesson team up in Germany
Aimed at achieving better scale, Walgreens Boots Alliance (NASDAQ:WBA) and McKesson (NYSE:MCK) will combine their respective wholesale businesses in Germany, Alliance Healthcare Deutschland and GEHE Pharma Handel. WBA will own 70% of the joint venture (JV) while MCK will own 30%. The transaction should close in six months or more. Financial terms are not disclosed.
2019-12-13T00:00:00
2019-12-13T00:00:00
54.779999
57.380001
59.650002
61.209999
59.490002
58.669998
59.240002
62.25
62.720001
62.25
61.939999
62.139999
61.939999
61.450001
61.34
60.619999
60.599998
60.669998
59.630001
60.110001
59.599998
59.27
58.990002
58.91
59.099998
58.630001
58.709999
58.41
58.009998
58.580002
57.880001
57.799999
57.09
57.200001
57.75
58.389999
58.57
58.349998
58.900002
59.02
58.91
58.959999
59.080002
59.080002
59.59
59.290001
2019-12-17
WBA
CVS and Walgreens in red on NY lawsuit over billing practices
CVS Health (CVS -0.8%) and Walgreens Boots Alliance (WBA -1.3%) are both near session lows in apparent response to reports that pharmacy benefit provider (PBM) CVS Omnicare has been sued in New York over alleged fraudulent billing practices. In May 2017, Omnicare paid $8M to settle a whistleblower-instigated lawsuit filed by the federal government and 28 states over charges that its prescription verification system generated false claims submitted to government healthcare programs, specifically, claims for more profitable generic drugs than those dispensed to patients. PBM-related tickers: Humana (HUM -0.8%), UnitedHealth Group (UNH -0.4%), Magellan Health (MGLN -1.3%), Cigna (CI -1%), Anthem (ANTM -0.3%), Centene (CNC -1.3%)
2019-12-18T00:00:00
2019-12-18T00:00:00
61.209999
59.490002
58.669998
59.240002
62.25
62.720001
62.25
61.939999
62.139999
61.939999
61.450001
61.34
60.619999
60.599998
60.669998
59.630001
60.110001
59.599998
59.27
58.990002
58.91
59.099998
58.630001
58.709999
58.41
58.009998
58.580002
57.880001
57.799999
57.09
57.200001
57.75
58.389999
58.57
58.349998
58.900002
59.02
58.91
58.959999
59.080002
59.080002
59.59
59.290001
55.830002
54.68
54.220001
2020-01-01
WBA
2019 leaders and laggards
Leaders Dow: Apple (NASDAQ:AAPL) +86%, Microsoft (NASDAQ:MSFT) +55%, JPMorgan (NYSE:JPM) +43%, Visa (NYSE:V) +42%, United Technologies (NYSE:UTX) +41%. S&P 500: Advanced Micro Devices (NASDAQ:AMD) +148%, Lam Research (NASDAQ:LRCX) +115%, KLA (NASDAQ:KLAC) +99%, Target (NYSE:TGT) +94%, Chipotle (NYSE:CMG) +94%. Nasdaq 100: Advanced Micro Devices (AMD) +148%, Lam Research (LRCX) +115%, Seattle Genetic (NASDAQ:SGEN) +102%, KLA (KLAC) +99%, MercadoLibre (NASDAQ:MELI) +95%. Laggards Dow: Walgreens (NASDAQ:WBA) -14%, Pfizer (NYSE:PFE) -10%, 3M (NYSE:MMM) -7%, Boeing (NYSE:BA) +1%, Exxon Mobil (NYSE:XOM) +2%. S&P 500: Fossil Group (NASDAQ:FOSL) -50%, Abiomed (NASDAQ:ABMD) -48%, Macy's (NYSE:M) -43%, Macerich (NYSE:MAC) -38%, TripAdvisor (NASDAQ:TRIP) -37%. Nasdaq 100: Kraft Heinz (NASDAQ:KHC) -25%, Baidu (NASDAQ:BIDU) -20%, Walgreens (WBA) -14%, American Airlines (NASDAQ:AAL) -11%, Expedia (NASDAQ:EXPE) -4%. *Stocks only include those which ended 2019 on the list of each index.
2020-01-02T00:00:00
2020-01-02T00:00:00
61.939999
61.450001
61.34
60.619999
60.599998
60.669998
59.630001
60.110001
59.599998
59.27
58.990002
58.91
59.099998
58.630001
58.709999
58.41
58.009998
58.580002
57.880001
57.799999
57.09
57.200001
57.75
58.389999
58.57
58.349998
58.900002
59.02
58.91
58.959999
59.080002
59.080002
59.59
59.290001
55.830002
54.68
54.220001
54.060001
54.619999
54.43
54.419998
54.41
53.869999
53.419998
53.299999
52.040001
2019-12-31
WBA
Apple, Microsoft top Dow 2019 standings; Walgreens wobbles to the bottom
Apple (NASDAQ:AAPL) and Microsoft (NASDAQ:MSFT) finished as the year's top gainers on the Dow Jones Industrial Average, as 27 of the 30 stocks in the index ended in the green vs. just 14 closing positive a year ago; the DJIA gained 22.3% on the year. The Dow top 10: 1. Apple +86.2%, 2. Microsoft +55.2%, 3. JPMorgan Chase (NYSE:JPM) +42.8%, 4. Visa (NYSE:V) +42.4%, 5. United Technologies (NYSE:UTX) +40.6%, 6. Goldman Sachs (NYSE:GS) +37.6%, 7. Nike (NYSE:NKE) +36.6%, 8. Procter & Gamble (NYSE:PG) +35.9%, 9. Disney (NYSE:DIS) +31.9%, 10. American Express (NYSE:AXP) +30.6%. 11. Walmart (NYSE:WMT) +27.6%, 12. Intel (NASDAQ:INTC) +27.5%, 13. Home Depot (NYSE:HD) +27.1%, 14. Merck (NYSE:MRK) +19%, 15. United Health (NYSE:UNH) +18%, 16. IBM (NYSE:IBM) +17.9%, 17. Coca-Cola (NYSE:KO) +16.9%, 18. Caterpillar (NYSE:CAT) +16.2%, 19. Travelers (NYSE:TRV) +14.3%, 20. Johnson & Johnson (NYSE:JNJ) +13%. 21. McDonald's (NYSE:MCD) +11.3%, 22. Chevron (NYSE:CVX) +10.7%, 23. Cisco (NASDAQ:CSCO) +10.7%, 24. Dow Inc. (NYSE:DOW) +9.9%, 25. Verizon (NYSE:VZ) +9.2%, 26. Exxon Mobil (NYSE:XOM) +2.3%, 27. Boeing (NYSE:BA) +1%, 28. 3M (NYSE:MMM) -7.4%, 29. Pfizer (NYSE:PFE) -10.2%, 30. Walgreen (NASDAQ:WBA) -13.7%. Dow Inc. is a spinoff of DowDuPont, which it replaced in the DJIA on April 2, 2019.
2020-01-01T00:00:00
2020-01-02T00:00:00
61.939999
61.450001
61.34
60.619999
60.599998
60.669998
59.630001
60.110001
59.599998
59.27
58.990002
58.91
59.099998
58.630001
58.709999
58.41
58.009998
58.580002
57.880001
57.799999
57.09
57.200001
57.75
58.389999
58.57
58.349998
58.900002
59.02
58.91
58.959999
59.080002
59.080002
59.59
59.290001
55.830002
54.68
54.220001
54.060001
54.619999
54.43
54.419998
54.41
53.869999
53.419998
53.299999
52.040001
2020-01-08
WBA
Walgreens -5% after earnings fall short
Walgreens Boots Alliance (NASDAQ:WBA) heads lower after missing FQ1 earnings estimates and maintaining full-year EPS guidance for "roughly flat" growth. Comparable sales in the U.S. rose 1.6% during the quarter as a 2.5% jump in the pharmacy comp was offset by a 0.5% retail comp decline. Gross margin was 21.3% of sales vs. 21.7% consensus. Operating income was reported at $1.16B vs. $1.24B consensus. "We are confident our strategic plans are the right ones to drive long-term sustainable growth going forward," says Walgreens CEO Stefano Pessina. Shares of Walgreens are down 5.21% premarket to $56.10 to trade at their lowest level since November. Previously: Walgreens Boots EPS misses by $0.04, misses on revenue (Jan. 8)
2020-01-09T00:00:00
2020-01-09T00:00:00
60.669998
59.630001
60.110001
59.599998
59.27
58.990002
58.91
59.099998
58.630001
58.709999
58.41
58.009998
58.580002
57.880001
57.799999
57.09
57.200001
57.75
58.389999
58.57
58.349998
58.900002
59.02
58.91
58.959999
59.080002
59.080002
59.59
59.290001
55.830002
54.68
54.220001
54.060001
54.619999
54.43
54.419998
54.41
53.869999
53.419998
53.299999
52.040001
52.23
52.779999
52.279999
51.950001
50.849998
2020-01-08
WBA
Walgreens Boots EPS misses by $0.04, misses on revenue
Walgreens Boots (NASDAQ:WBA): Q1 Non-GAAP EPS of $1.37 misses by $0.04; GAAP EPS of $0.95 misses by $0.20. Revenue of $34.34B (+1.6% Y/Y) misses by $110M. Press Release
2020-01-09T00:00:00
2020-01-09T00:00:00
60.669998
59.630001
60.110001
59.599998
59.27
58.990002
58.91
59.099998
58.630001
58.709999
58.41
58.009998
58.580002
57.880001
57.799999
57.09
57.200001
57.75
58.389999
58.57
58.349998
58.900002
59.02
58.91
58.959999
59.080002
59.080002
59.59
59.290001
55.830002
54.68
54.220001
54.060001
54.619999
54.43
54.419998
54.41
53.869999
53.419998
53.299999
52.040001
52.23
52.779999
52.279999
51.950001
50.849998
2020-01-07
WBA
Walgreens Boots Q1 2020 Earnings Preview
Walgreens Boots (NASDAQ:WBA) is scheduled to announce Q1 earnings results on Wednesday, January 8th, before market open. The consensus EPS Estimate is $1.41 (-3.4% Y/Y) and the consensus Revenue Estimate is $34.45B (+1.9% Y/Y). Over the last 2 years, WBA has beaten EPS estimates 88% of the time and has beaten revenue estimates 63% of the time. Over the last 3 months, EPS estimates have seen 8 upward revisions and 7 downward. Revenue estimates have seen 4 upward revisions and 9 downward.
2020-01-08T00:00:00
2020-01-08T00:00:00
60.599998
60.669998
59.630001
60.110001
59.599998
59.27
58.990002
58.91
59.099998
58.630001
58.709999
58.41
58.009998
58.580002
57.880001
57.799999
57.09
57.200001
57.75
58.389999
58.57
58.349998
58.900002
59.02
58.91
58.959999
59.080002
59.080002
59.59
59.290001
55.830002
54.68
54.220001
54.060001
54.619999
54.43
54.419998
54.41
53.869999
53.419998
53.299999
52.040001
52.23
52.779999
52.279999
51.950001
2020-01-09
WBA
Pharmacy chains sue Ohio doctors over role in opioid epidemic
Retail pharmacy operators Walgreens (WBA -1.5%), CVS Health (CVS +0.2%), Walmart (WMT +0.4%) and Rite Aid (RAD -2.7%) have filed litigation against over-prescribing doctors in Ohio who operated "pill mills" responsible for up to 60% of the opioids dispensed in the area. The trial is set to begin on October 13.
2020-01-10T00:00:00
2020-01-10T00:00:00
59.630001
60.110001
59.599998
59.27
58.990002
58.91
59.099998
58.630001
58.709999
58.41
58.009998
58.580002
57.880001
57.799999
57.09
57.200001
57.75
58.389999
58.57
58.349998
58.900002
59.02
58.91
58.959999
59.080002
59.080002
59.59
59.290001
55.830002
54.68
54.220001
54.060001
54.619999
54.43
54.419998
54.41
53.869999
53.419998
53.299999
52.040001
52.23
52.779999
52.279999
51.950001
50.849998
50.950001
2020-02-05
WBA
New chief at Walgreens
Walgreens Boots Alliance (NASDAQ:WBA +1.5%) appoints Richard Ashworth as President of Walgreens. Previously, the 28-year veteran was President of Operations, Walgreens.
2020-02-06T00:00:00
2020-02-06T00:00:00
58.57
58.349998
58.900002
59.02
58.91
58.959999
59.080002
59.080002
59.59
59.290001
55.830002
54.68
54.220001
54.060001
54.619999
54.43
54.419998
54.41
53.869999
53.419998
53.299999
52.040001
52.23
52.779999
52.279999
51.950001
50.849998
50.950001
52.34
52.98
53.490002
53.240002
53.419998
52.990002
54.470001
53.57
52.849998
51.860001
52.07
51.869999
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
2020-02-06
WBA
Goldman expects dividend all-stars to outperform
Goldman Sachs is promoting its select portfolio that tracks stocks with high dividend growth. The 46-stock portfolio has double the S&P 500's returns so far this year and is the best performing basket among the 46 Goldman portfolios. To create the list, GS screened for stocks expected to raise their dividends by an annualized rate of 9% through 2021. The portfolio of dividend all-stars includes AT&T (NYSE:T), Abbvie (NYSE:ABBV), Valero Energy (NYSE:VLO), Huntington Bancshares (NASDAQ:HBAN), Broadcom (NASDAQ:AVGO), IBM (NYSE:IBM), Pfizer (NYSE:PFE), Molson Coors (NYSE:TAP), Walgreen Boots Alliance (NASDAQ:WBA), and Cummins (NYSE:CMI).
2020-02-07T00:00:00
2020-02-07T00:00:00
58.349998
58.900002
59.02
58.91
58.959999
59.080002
59.080002
59.59
59.290001
55.830002
54.68
54.220001
54.060001
54.619999
54.43
54.419998
54.41
53.869999
53.419998
53.299999
52.040001
52.23
52.779999
52.279999
51.950001
50.849998
50.950001
52.34
52.98
53.490002
53.240002
53.419998
52.990002
54.470001
53.57
52.849998
51.860001
52.07
51.869999
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
2020-02-18
WBA
Opioid-related payouts to be less than expected - NYT
The New York Times reports that lawyers representing U.S. states and cities suing opioid markers and distributors now concede that the prospective payouts will be much less than originally expected. Attorneys from all sides have ramped up efforts to reach a national settlement before the start of a New York trial next month. The total amount will likely be less than half of what four large tobacco companies agreed to pay (more than $206B over 25 years) in 1998. In an interview, chief negotiator Joe Rice said, "People would say I was crazy if I thought we could get over $100 billion.” Nephron Research's Eric Percher, who is following the litigation, believes the amount will be $75B - 85B. Selected tickers: ABC, CAH, MCK, JNJ, ENDP, MNK, TEVA, CVS, WMT, WBA See the latest on the opioid crisis and the stocks impacted.
2020-02-19T00:00:00
2020-02-19T00:00:00
59.59
59.290001
55.830002
54.68
54.220001
54.060001
54.619999
54.43
54.419998
54.41
53.869999
53.419998
53.299999
52.040001
52.23
52.779999
52.279999
51.950001
50.849998
50.950001
52.34
52.98
53.490002
53.240002
53.419998
52.990002
54.470001
53.57
52.849998
51.860001
52.07
51.869999
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
2020-02-21
WBA
Major pharmacy chains downplay rates of prescription mistakes
In a follow-up to its first article published last month, The New York Times reports that major pharmacy operators Walgreens (WBA -0.7%) and CVS (CVS -0.6%) continue to push back on complaints from pharmacists that high levels of job stress and "unreasonable" expectations from headquarters lead to mistakes filling prescriptions while bypassing safety procedures. CVS pharmacists cite similar issues to Walgreens, including insufficient staffing, that lead to mistakes. Both companies deny that there is a systematic problem, saying that reports garnered to date represent only a tiny fraction of locations and staff. Pharmacists counter that the volume of daily tasks, filling prescriptions, giving flu shots, answering phones, managing the drive-through, in addition to meeting corporate metrics, make it a struggle to keep up, thereby increasing the risk of errors. Walgreens apparently did itself no favors in its handling of a presentation by Tata Consultancy Services, an IT firm that recently announced a $1.5B deal to run its technology operations. During on-site interviews in certain pharmacies aimed at gaining a better understanding of how employees use the computer system, Tata representatives heard complaints about the work environment and dutifully included slides in their draft presentation on stress-related errors and safety concerns, slides Walgreens removed from the final presentation. Pharmacist Moms, a group of 32K female pharmacists, recently posted a letter on its website and social media accounts that patient safety "may be compromised due to overly stressful working conditions at certain pharmacies." Related tickers: Rite Aid (RAD +5.2%), Walmart (WMT +0.6%), Target (TGT -0.5%), Costco (COST -0.5%)
2020-02-22T00:00:00
2020-02-24T00:00:00
54.68
54.220001
54.060001
54.619999
54.43
54.419998
54.41
53.869999
53.419998
53.299999
52.040001
52.23
52.779999
52.279999
51.950001
50.849998
50.950001
52.34
52.98
53.490002
53.240002
53.419998
52.990002
54.470001
53.57
52.849998
51.860001
52.07
51.869999
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
2020-03-02
WBA
Stockpiling in U.S. lifts grocery, drugstore stocks
Grocery store and drugstore stocks are shooting higher after the new cases of coronavirus in the U.S. send consumers rushing out to buy food, water and medicine. Notable gainers include Kroger (KR +4.4%), Walgreens Boots Alliance (WBA +2.6%), CVS Health (CVS +4.4%), Sprouts Farmers Market (SFM +3.1%), Weis Markets (WMK +3.1%), Ingles Markets (IMKTA +2.6%) and Natural Grocers by Vitamin Cottage (NGVC +6.8%). The next question for investors will be if the stockpiling sales were just pulled forward from a future date or incremental? Previously: Big let's-stock-up rally in retail (March 2)
2020-03-03T00:00:00
2020-03-03T00:00:00
54.41
53.869999
53.419998
53.299999
52.040001
52.23
52.779999
52.279999
51.950001
50.849998
50.950001
52.34
52.98
53.490002
53.240002
53.419998
52.990002
54.470001
53.57
52.849998
51.860001
52.07
51.869999
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
2020-03-04
WBA
Bed Bath gets a new chief merchandising officer
It's the first major hire for CEO Mark Tritton since he joined the company in late 2019. Bed Bath & Beyond (NASDAQ:BBBY) has tapped Walgreens' (NASDAQ:WBA) Chief Merchandising Officer Joe Hartsig to become its chief merchant as the struggling retailer looks to turn itself around. Hartsig will also become president of Bed Bath's Harmon Stores business - which oversees shops that sells cosmetics, health essentials and beauty items - effective immediately. "To rebuild our business, we need leaders of change," Tritton said in a statement.
2020-03-05T00:00:00
2020-03-05T00:00:00
53.419998
53.299999
52.040001
52.23
52.779999
52.279999
51.950001
50.849998
50.950001
52.34
52.98
53.490002
53.240002
53.419998
52.990002
54.470001
53.57
52.849998
51.860001
52.07
51.869999
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
2020-03-09
WBA
CVS waives charges for home delivery of medicines
Citing the number of people who are staying home amid the COVID-19 outbreak, CVS Health (CVS -3.6%) has taken the additional step of eliminating charges for the home delivery of drugs. Other pharmacy chains are likely to follow CVS' lead. Related tickers: WBA, RAD
2020-03-10T00:00:00
2020-03-10T00:00:00
52.23
52.779999
52.279999
51.950001
50.849998
50.950001
52.34
52.98
53.490002
53.240002
53.419998
52.990002
54.470001
53.57
52.849998
51.860001
52.07
51.869999
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
2020-03-13
WBA
Walgreens, Kroger limit some product purchases
As customers stock up on essentials due to the coronavirus pandemic, Kroger (NYSE:KR) has placed a limit on the number of cold, flu and sanitary products per order. A spokeswoman for Walgreens (NASDAQ:WBA) said the company was also limiting disinfectant wipes and cleaners, face masks, hand sanitizers, thermometers and gloves to four each per customer.
2020-03-14T00:00:00
2020-03-16T00:00:00
50.849998
50.950001
52.34
52.98
53.490002
53.240002
53.419998
52.990002
54.470001
53.57
52.849998
51.860001
52.07
51.869999
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
2020-03-12
WBA
Walgreens cuts fees amid coronavirus outbreak
Following CVS's lead, Walgreens (NASDAQ:WBA) is waiving delivery fees for all eligible prescriptions in an effort to help customers and patients during the COVID-19 outbreak. It reminds customers that it will continue to operate its drive-throughs at pharmacies, Walgreens Pharmacy Chat, its 24/7 online platform, and its mobile app. Also consistent with other retailers, it has instituted purchase limits on selected products to ensure that they remain widely available. Shares down 1% after-hours.
2020-03-13T00:00:00
2020-03-13T00:00:00
51.950001
50.849998
50.950001
52.34
52.98
53.490002
53.240002
53.419998
52.990002
54.470001
53.57
52.849998
51.860001
52.07
51.869999
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
2020-03-13
WBA
Walgreens to provide space for COVID-19 testing
Touting its commitment to do its part in battling the COVID-19 outbreak, Walgreens (NASDAQ:WBA) will allocate temporary space at select locations outside of stores where non-Walgreens personnel will administer tests for SARS-CoV-2. The company will announce the locations at a later date in collaboration with the CDC and Centers for Medicare and Medicaid Services. Yesterday, it announced certain measures to help customers and patients during the outbreak.
2020-03-14T00:00:00
2020-03-16T00:00:00
50.849998
50.950001
52.34
52.98
53.490002
53.240002
53.419998
52.990002
54.470001
53.57
52.849998
51.860001
52.07
51.869999
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
2020-03-13
WBA
President Trump declares national emergency over coronavirus
President Trump officially declares a national emergency, which will unlock access to $50B in funds. He's asking hospitals to activate emergency plans. The order also gives broad authority to the U.S.Health & Human Service Department. Includes ability to waive some federal laws to allow telemedicine. Will waive interest on all student loans held by government agencies. Will also purchase more crude oil to add to the strategic petroleum reserve. "We're going to fill it up right to the top," he said. CMS director Seema Varma says the declaration will "suspend regulations that could get in the way of treating patients." She announced that nursing homes will restrict non-medically-necessary visitors. Trump says a half million more coronavirus tests will be available next week. "We'll have the ability to do millions of tests in a very, very short period of time," he said. There will be some U.S. partnering with the private sector to increase testing. Google (GOOG +5.9%) is helping to develop a website where people can find drive-through testing sites if they have symptoms, according to Dr. Deborah Birx, White House Coronavirus Response Coordinator. The website will be online starting Sunday evening, Trump said. Walmart (WMT +6.7%), CVS (CVS +8.6%), Walgreens (WBA +9.2%), Target (TGT +9.7%), Roche Diagnostics (OTCQX:RHHBY), LabCorp (LH +8.6%), Quest Diagnostics (DGX) and Becton Dickinson (BDX +6.2%) are among companies working with the government. He doesn't want everyone "running out and taking a test." Only those exhibiting certain symptoms should get tested, he said. "We will overcome the threat of the virus," he said. "This will pass through and we will be even stronger for it," he said as he was wrapping up his address. "We're learning a lot for future problems or worse, it could get worse," Trump said. When asked about Trump's contact with an individual who has tested positive for coronavirus, he said he didn't know that person and his contact was probably only a couple of seconds. Still, he said he'll "most likely" get tested for Covid-19, but not because of this contact with the infected individual. Regarding domestic travel, "If you stay home, it's not bad," he said. Press conference ends at ~4:45 PM ET.
2020-03-14T00:00:00
2020-03-16T00:00:00
50.849998
50.950001
52.34
52.98
53.490002
53.240002
53.419998
52.990002
54.470001
53.57
52.849998
51.860001
52.07
51.869999
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
2020-03-18
WBA
Walgreens cuts store hours amid Covid-19
Citing the need for enough time to clean and sanitize stores and restock shelves during the coronavirus outbreak, Walgreens (NASDAQ:WBA +4.8%) will reduce in-store operating hours to 9 am - 9 pm during weekdays and over weekends until further notice (weekend pharmacy hours will remain largely unchanged). 24-hour drive-thru service at offering stores will remain open as usual. Related tickers: CVS Health (CVS +0.2%), Rite Aid (RAD +9.8%)
2020-03-19T00:00:00
2020-03-19T00:00:00
52.98
53.490002
53.240002
53.419998
52.990002
54.470001
53.57
52.849998
51.860001
52.07
51.869999
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
42.810001
43.09
43.98
2020-03-23
WBA
26 Benjamin Graham-inspired stock picks
Goldman's David Kostin screened S&P 500 stocks looking for "Benjamin Graham-inspired safety stocks" that he says based on size, liquidity, balance sheet strength, and valuation, offer a margin of safety. Specifically, he screened for i) market capitalization of more than $10B, ii) higher liquidity than other S&P 500 constituents, iii) better relative balance sheet strength, and iv) trade at valuations no more than 20% above theirs at the market’s weakest point in 2009. Here's the list: Alexion Pharma (NASDAQ:ALXN) Align Technology (NASDAQ:ALGN) Intel (NASDAQ:INTC) Analog Devices (NASDAQ:ADI) Texas Instruments (NASDAQ:TXN) Take Two Interactive (NASDAQ:TTWO) Qualcomm (NASDAQ:QCOM) Maxim Integrated Products (NASDAQ:MXIM) T Rowe Price (NASDAQ:TROW) Gilead (NASDAQ:GILD) Salesforce (NYSE:CRM) Bristol-Myers Squibb (NYSE:BMY) Skyworks Solutions (NASDAQ:SWKS) Lowe's (NYSE:LOW) Best Buy (NYSE:BBY) Walgreens Boots Alliance (NASDAQ:WBA) Booking Holdings (NASDAQ:BKNG) Illumina (NASDAQ:ILMN) Electronic Arts (NASDAQ:EA) McKesson (NYSE:MCK) Altria (NYSE:MO) UPS (NYSE:UPS) Biogen (NASDAQ:BIIB) Xilinx (NASDAQ:XLNX) Cognizant Technology (NASDAQ:CTSH) Quest Diagnostics (NYSE:DGX)
2020-03-24T00:00:00
2020-03-24T00:00:00
53.419998
52.990002
54.470001
53.57
52.849998
51.860001
52.07
51.869999
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
42.810001
43.09
43.98
44.110001
46.380001
43.439999
2020-03-26
WBA
Conserving potential coronavirus treatments
CVS Health (NYSE:CVS) and Express Scripts, which is part of Cigna (NYSE:CI) are putting in place measures to prevent hoarding of the malaria drug hydroxychloroquine and others being tried against COVID-19. The treatments, touted by President Trump, are being embraced because there are no approved vaccines or treatments against the highly contagious respiratory illness. Walgreens (NASDAQ:WBA) now has a 14-day limit for new prescriptions, a 30-day supply limit for refills, and a reduction in 90-day prescriptions to 30 days.
2020-03-27T00:00:00
2020-03-27T00:00:00
53.57
52.849998
51.860001
52.07
51.869999
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
42.810001
43.09
43.98
44.110001
46.380001
43.439999
43.23
44.5
42.849998
2020-04-02
WBA
Rough session for pharmacies after Walgreens updates on March
via Bertha Coombs at CNBC Speaking on the earnings call, Walgreens (WBA -8.1%) management notes initially strong growth in a number of categories in early-mid March, but a more-recent drop-off in spending on discretionary items like beauty, and a fall in foot traffic (this morning's results were for the quarter ended on Feb. 29). In the U.K., for instance, sales are down 65% over the last 10 days as it appears folks pulled forward scripts and got larger quantities than needed. CEO Stefano Pessina: For pharmacy, people are trying to use whatever they have at home, and going to the store only if necessary. If the lockdown only goes on for another month, he expects customers to return to old habits. If things take longer, all bets are off. CVS (CVS -6.6%), Rite-Aid (RAD -15.9%)
2020-04-03T00:00:00
2020-04-03T00:00:00
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
42.810001
43.09
43.98
44.110001
46.380001
43.439999
43.23
44.5
42.849998
42.549999
43.310001
43.5
43.740002
44.43
2020-04-02
WBA
Walgreens pulls guidance, reiterates cost-savings on track
Prior to COVID-19, the company was on track to maintain its F2020 guidance of roughly flat adjusted EPS, but that's been pulled. More updates to come with next earnings report. Walgreens (NASDAQ:WBA) remains on track to deliver more than $1.8B of cost savings by F2022. Conference call is at 8:30 ET. Previously: Walgreens Boots EPS beats by $0.06, beats on revenue (April 2) Shares are up 3.4% premarket.
2020-04-03T00:00:00
2020-04-03T00:00:00
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
42.810001
43.09
43.98
44.110001
46.380001
43.439999
43.23
44.5
42.849998
42.549999
43.310001
43.5
43.740002
44.43
2020-04-02
WBA
Walgreens Boots EPS beats by $0.06, beats on revenue
Walgreens Boots (NASDAQ:WBA): Q2 Non-GAAP EPS of $1.52 beats by $0.06; GAAP EPS of $1.07 misses by $0.10. Revenue of $35.82B (+3.7% Y/Y) beats by $580M. Shares +1% PM. Press Release
2020-04-03T00:00:00
2020-04-03T00:00:00
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
42.810001
43.09
43.98
44.110001
46.380001
43.439999
43.23
44.5
42.849998
42.549999
43.310001
43.5
43.740002
44.43
2020-04-01
WBA
Walgreens Boots Q2 2020 Earnings Preview
Walgreens Boots (NASDAQ:WBA) is scheduled to announce Q2 earnings results on Thursday, April 2nd, before market open. The consensus EPS Estimate is $1.46 (-11.0% Y/Y) and the consensus Revenue Estimate is $35.24B (+2.1% Y/Y). Over the last 2 years, WBA has beaten EPS estimates 75% of the time and has beaten revenue estimates 50% of the time. Over the last 3 months, EPS estimates have seen 0 upward revisions and 20 downward. Revenue estimates have seen 8 upward revisions and 7 downward. Recent earnings Analysis from our contributors:Walgreens Earnings Preview: EPS And Revenue Estimate Trends Not Encouraging
2020-04-02T00:00:00
2020-04-02T00:00:00
51.869999
51.450001
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
42.810001
43.09
43.98
44.110001
46.380001
43.439999
43.23
44.5
42.849998
42.549999
43.310001
43.5
43.740002
2020-04-03
WBA
Jefferies sees 93% upside in Avadel Pharma in premarket analyst action
Arcus Biosciences (NYSE:RCUS) initiated with an Overweight rating and a $21 (41% upside) price target at Cantor Fitzgerald. Avadel Pharmaceuticals (NASDAQ:AVDL) initiated with a Buy rating and a $14 (93% upside) price target at Jefferies. Integra LifeSciences Holdings (NASDAQ:IART) initiated with a Buy rating and a $55 (30% upside) price target at SunTrust. SeaSpine Holdings (NASDAQ:SPNE) initiated with a Buy rating and a $15 (96% upside) price target at SunTrust. Walgreens Boots Alliance (NASDAQ:WBA) upgraded to Hold with a $43 (7% upside) price target at Deutsche Bank. Immunomedics (NASDAQ:IMMU) downgraded to Sell with a $5 (53% downside risk) price target at Goldman Sachs. Shares down 6% premarket on delay in scaling up manufacturing of antibody-drug conjugate sacituzumab govitecan. Precision BioSciences (NASDAQ:DTIL) downgraded to Neutral with a $7 (26% upside) price target at Goldman.
2020-04-04T00:00:00
2020-04-06T00:00:00
49.029999
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
42.810001
43.09
43.98
44.110001
46.380001
43.439999
43.23
44.5
42.849998
42.549999
43.310001
43.5
43.740002
44.43
44.650002
2020-04-06
WBA
Jefferies sees 51% upside in Jazz Pharma in premarket analyst action
Jazz Pharmaceuticals (NASDAQ:JAZZ) initiated with Buy rating and $149 (51% upside) price target at Jefferies. Walgreens Boots Alliance (NASDAQ:WBA) upgraded to Neutral with a $44 (8% upside) price target at UBS. Shares up 2% premarket. Acceleron Pharma (NASDAQ:XLRN) downgraded to Sell with a $73 (10% downside risk) price target at Goldman Sachs. Viela Bio (NASDAQ:VIE) downgraded to Sell with a $36 (17% upside) price target at Goldman.
2020-04-07T00:00:00
2020-04-07T00:00:00
47.509998
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
42.810001
43.09
43.98
44.110001
46.380001
43.439999
43.23
44.5
42.849998
42.549999
43.310001
43.5
43.740002
44.43
44.650002
45.360001
2020-04-07
WBA
Bristol-Myers Squibb to provide medicines to the unemployed and uninsured
New COVID-19 initiatives/developments from healthcare companies include Bristol-Myers Squibb's (NYSE:BMY) expansion of its existing patient support program aimed at helping unemployed U.S. patients who have lost their health insurance coverage due to the pandemic. The company is offering its branded medicines at no charge, including those prescribed via telehealth services. Shares up 2% premarket. Karyopharm Therapeutics (NASDAQ:KPTI) plans to launch a global clinical trial evaluating low-dose Xpovio (selinexor) in severely ill hospitalized COVID-19 patients. Teva Pharmaceutical Industries (NYSE:TEVA) Canadian unit and Huddol are offering free virtual personal assistance services to families for 30 days via Huddol.com during the pandemic supported by funding from Teva. Afterward, services will be available at a discount. Shares up 3% premarket. Infinity Pharmaceuticals (NASDAQ:INFI) expects enrollment to be delayed in its clinical trials as well as new site activations. Supply chain unaffected thus far. Walgreens (NASDAQ:WBA) is working to expand drive-through COVID-19 testing to 15 locations in seven states (AZ, FL, IL, KY, LA, TN and TX). The sites will use Abbott's (NYSE:ABT) ID NOW rapid test. WBA and ABT both up 1% premarket. Tauriga Sciences (OTCPK:TAUG) will collaborate with Aegea Biotechnologies to develop a rapid PCR test for SARS-CoV-2. IQVIA (NYSE:IQV) launches a registry, IQVIA CARE Project, aimed at advancing understanding of the disease. Vertex Pharmaceuticals' (NASDAQ:VRTX) non-profit charitable foundation to donate $5M to support global relief efforts.
2020-04-08T00:00:00
2020-04-08T00:00:00
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
42.810001
43.09
43.98
44.110001
46.380001
43.439999
43.23
44.5
42.849998
42.549999
43.310001
43.5
43.740002
44.43
44.650002
45.360001
43.290001
2020-04-07
WBA
Walgreens sets $500M revolving credit line
Walgreens Boots Alliance (NASDAQ:WBA) has entered into an agreement for a $500M revolving credit facility. It comes via HSBC. It's a 364-day senior unsecured facility that allows for borrowing U.S. dollars, pounds and euro.
2020-04-08T00:00:00
2020-04-08T00:00:00
47.669998
46.240002
45.759998
48.110001
46.119999
48.689999
48.779999
50.509998
48.439999
49.16
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
42.810001
43.09
43.98
44.110001
46.380001
43.439999
43.23
44.5
42.849998
42.549999
43.310001
43.5
43.740002
44.43
44.650002
45.360001
43.290001
2020-04-22
WBA
Walgreens Boots declares $0.4575 dividend
Walgreens Boots (NASDAQ:WBA) declares $0.4575/share quarterly dividend, in line with previous. Forward yield 4.26% Payable June 12; for shareholders of record May 20; ex-div May 19. See WBA Dividend Scorecard, Yield Chart, & Dividend Growth.
2020-04-23T00:00:00
2020-04-23T00:00:00
46.07
41.02
46.189999
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
42.810001
43.09
43.98
44.110001
46.380001
43.439999
43.23
44.5
42.849998
42.549999
43.310001
43.5
43.740002
44.43
44.650002
45.360001
43.290001
41.66
42.450001
42.02
41.200001
40.66
41.669998
41.709999
40.529999
38.349998
38.849998
2020-04-27
WBA
CVS and Walgreens to greatly boost testing availability
CVS Health (NYSE:CVS) says it will join other pharmacy chains and retailers at the White House today to announce the next phase in COVID-19 testing. Beginning in May, it will offer self-swabs to people meeting CDC criteria for testing in parking lot sites or via drive-through windows. It expects to have up to 1,000 locations in the U.S. operating as collection sites with a goal of processing up to 1.5M tests/month subject to supplies. No testing will be done in stores. It currently operates large-scale collection sites in five states. Most can collect up to 1,000 tests/day. Update: Walgreens (NASDAQ:WBA) plans to open collection sites in 49 states and Puerto Rico with a focus on underserved communities. It expects to test more than 50K people per week using LabCorp's (NYSE:LH) collection kit, approved by the FDA last week. Currently, it has 18 drive-through sites across 11 states and plans to have 23 sites across 15 states by the end of this week, all by appointment only. LH is up 1% after hours.
2020-04-28T00:00:00
2020-04-28T00:00:00
45.080002
49.599998
52.810001
48.549999
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
42.810001
43.09
43.98
44.110001
46.380001
43.439999
43.23
44.5
42.849998
42.549999
43.310001
43.5
43.740002
44.43
44.650002
45.360001
43.290001
41.66
42.450001
42.02
41.200001
40.66
41.669998
41.709999
40.529999
38.349998
38.849998
38.400002
40.860001
39.77
2020-05-01
WBA
Odeon finds retail opportunities, 'generational' mall prospects
With economies making more than baby steps into reopening in some states, Odeon's latest Consumer Pulse look starts to pick through beaten-down names - whether essentials or not - as well as mall operators that are down 50% from this year's highs. The firm notes the early moves from Georgia and Texas to reopen retail, and cites a number of corporate decisions: Aside from Simon Property Group's (NYSE:SPG) plan to reopen 49 malls (concentrated in Texas and Georgia), it notes Macy's (NYSE:M) planning to reopen 68 doors next week; Dillard's (NYSE:DDS) to re-open 55 locations starting Tuesday; Stein Mart (NASDAQ:SMRT) planning to have a third of its doors open today, and accelerating from there; and At Home (NYSE:HOME) expecting to open 50% of stores to foot traffic today. Rent avoidance is on the wane, Odeon notes, using a simple rule of thumb: Closed retailers mostly didn't pay in April, and there's open debate about May, depending on the mix of tenants. (In mall REITs: Agree Realty (NYSE:ADC), heavy on essential retail, collected 87% of April rent; American Assets Trust (NYSE:AAT) by contrast collected 47%.) As for what's next, Odeon says "It makes sense that the Street has been hiding in names like Walmart (NYSE:WMT), Costco (NASDAQ:COST), BJ's Wholesale (NYSE:BJ), Ollie's Bargain Outlet (NASDAQ:OLLI), Walgreen Boots Alliance (NASDAQ:WBA) ... even Amazon.com (NASDAQ:AMZN) and GrubHub (NYSE:GRUB)," as they're "winners of the shutdown." But malls filled with punished names like American Eagle Outfitters (NYSE:AEO), Abercrombie & Fitch (NYSE:ANF), Chico's FAS (NYSE:CHS), Francesca's Holdings (NASDAQ:FRAN), The Gap (NYSE:GPS), Nordstrom (NYSE:JWN), L Brands (NYSE:LB), Macy's (M) and The Children's Place (NASDAQ:PLCE) are starting to re-open, it says. (Francesca's just raised the specter of a going concern warning after the pandemic's hit to revenue and cash flow.) "As the market roils into May, we believe that a pair trade of selling essentials into long bets on beaten-down retailers sounds blasphemous but is likely to work in the coming weeks," the firm says.
2020-05-02T00:00:00
2020-05-04T00:00:00
46.419998
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
42.810001
43.09
43.98
44.110001
46.380001
43.439999
43.23
44.5
42.849998
42.549999
43.310001
43.5
43.740002
44.43
44.650002
45.360001
43.290001
41.66
42.450001
42.02
41.200001
40.66
41.669998
41.709999
40.529999
38.349998
38.849998
38.400002
40.860001
39.77
40.139999
39.75
39.599998
42.16
2020-05-05
WBA
Most Walgreens back to regular hours
In another sign of the return of retail normalcy, Walgreens (NASDAQ:WBA) says it will resume normal operating stores at most stores in the U.S. Certain stores located in tourist regions, downtown city centers or markets with government-mandated curfews will continue to operate with adjusted hours. Source: Press Release
2020-05-06T00:00:00
2020-05-06T00:00:00
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
42.810001
43.09
43.98
44.110001
46.380001
43.439999
43.23
44.5
42.849998
42.549999
43.310001
43.5
43.740002
44.43
44.650002
45.360001
43.290001
41.66
42.450001
42.02
41.200001
40.66
41.669998
41.709999
40.529999
38.349998
38.849998
38.400002
40.860001
39.77
40.139999
39.75
39.599998
42.16
42.970001
41.830002
2020-05-04
WBA
AmerisourceBergen eyes Walgreens' drug distribution operation
According to Reuters, AmerisourceBergen (NYSE:ABC) has approached Walgreens Boots Alliance (NASDAQ:WBA) about a purchase of its pharmaceutical wholesaling division (known as Alliance Healthcare). ABC is willing to pay about $6B for the unit. WBA +1.9% after-hours.
2020-05-05T00:00:00
2020-05-05T00:00:00
43.610001
45.25
41.439999
45.669998
44
45.16
45.75
43.029999
40.32
40.720001
42.630001
42.810001
43.09
43.98
44.110001
46.380001
43.439999
43.23
44.5
42.849998
42.549999
43.310001
43.5
43.740002
44.43
44.650002
45.360001
43.290001
41.66
42.450001
42.02
41.200001
40.66
41.669998
41.709999
40.529999
38.349998
38.849998
38.400002
40.860001
39.77
40.139999
39.75
39.599998
42.16
42.970001
2020-05-17
WBA
Covid-19 update: CVS inks deal with New York to conduct more Covid testing
New York, the hardest hit in the U.S. has signed a deal with CVS for 60 locations to conduct more than 50 tests a day at each. That brings the total testing sites in NY to more than 700, Governor Cuomo stated in his daily press briefing. He mentioned NY now has more testing capacity than is needed, urging more New Yorkers to get tested. Attributes that allow one to get a test have now been broadened, including any worker involved in the Phase 1 reopening. Unclear if the model will be rolled out to other states and companies in which competitors like Walgreens Boots Alliance (NASDAQ:WBA), Rite Aid (NYSE:RAD) could be used. In other coronavirus news, Brazil has surpassed Italy in total number of cases, with reports of more than 15K new cases. India's cases now exceed China's. Experts on Brazil and India have separately indicated that the cases could be much higher than being reported due to the dearth of testing and data collection.
2020-05-18T00:00:00
2020-05-18T00:00:00
40.720001
42.630001
42.810001
43.09
43.98
44.110001
46.380001
43.439999
43.23
44.5
42.849998
42.549999
43.310001
43.5
43.740002
44.43
44.650002
45.360001
43.290001
41.66
42.450001
42.02
41.200001
40.66
41.669998
41.709999
40.529999
38.349998
38.849998
38.400002
40.860001
39.77
40.139999
39.75
39.599998
42.16
42.970001
41.830002
42.939999
43.299999
43.549999
43.610001
44.200001
45.349998
47.02
45.279999
2020-05-21
WBA
Odeon picks 'downtrodden' retail for reopening plays
Retail reopenings are moving steadily forward, and while it's early days, Odeon's Consumer Pulse is looking for "downtrodden" names that have room to run. We're "coming into the third inning" for reopenings, which means "miles to go" before normalcy, Alex Arnold writes. Most retailers are looking toward a full re-open by the end of July, while traffic/engagement may lag that a bit. On its checks (focused on traditional malls, but including off-mall venues and essential retailers), it sees demand returning ahead of expectations for malls and off-mall essential retailers. In particular, it's seeing a divide in the consumer group, as surging demand for essentials has drawn demand and dollars away from discretionary purchases such as apparel. "It is worth calling out that the greatest acceleration we’re seeing in May is in Home-related names (esp. Home Goods and WSM), Department Stores and Active/Athletics players (such as DKS)," the firm says. Arnold writes that "team Essential" - including Walmart (NYSE:WMT), Costco (NASDAQ:COST), Target (NYSE:TGT), Home Depot (NYSE:HD) and Lowe's (NYSE:LOW), Ollie's Bargain Outlet (NASDAQ:OLLI), Walgreens Boots Alliance (NASDAQ:WBA) and Kroger (NYSE:KR) - has picked up "significant ground, mindshare and goodwill through the pandemic that is likely to result in a sustainable firming of their foundations," but also a crowded trade. And it sees a significant reversion opportunity in the beaten-up side of the group that's now on the mend. Those names where it sees heavy relative multiple discounts (in order, from best): Designer Brands (DBI, with a multiple discount of 75%); Nordstrom (JWN, multiple discount of 58%); The Children's Place (NASDAQ:PLCE); Macy's (NYSE:M); Gap (NYSE:GPS); L Brands (NYSE:LB); American Eagle Outfitters (NYSE:AEO); Urban Outfitters (NASDAQ:URBN); Abercrombie & Fitch (NYSE:ANF); and Bed Bath & Beyond (NASDAQ:BBBY).
2020-05-22T00:00:00
2020-05-22T00:00:00
43.98
44.110001
46.380001
43.439999
43.23
44.5
42.849998
42.549999
43.310001
43.5
43.740002
44.43
44.650002
45.360001
43.290001
41.66
42.450001
42.02
41.200001
40.66
41.669998
41.709999
40.529999
38.349998
38.849998
38.400002
40.860001
39.77
40.139999
39.75
39.599998
42.16
42.970001
41.830002
42.939999
43.299999
43.549999
43.610001
44.200001
45.349998
47.02
45.279999
44.279999
40.75
41.400002
41.490002
2020-07-08
WBA
Walgreens goes big into primary care
Walgreens (NASDAQ:WBA) announces that it plans to establish primary care clinics in as many as 700 U.S. stores over the "next few years." It will partner with VillageMD to set up the doctor-led clinics which will also include nurses, social workers and therapists. To allow for the necessary space, it will redesign stores, including narrower shelves and less room (maybe no room) for tobacco products. Heretofore, Walgreens has tucked tiny clinics in the back of stores where customers can get flu shots or treatment of minor ailments. Last fall, it announced that it intended to close ~40% of those. Shares up 3% premarket on light volume. Related tickers: (NYSE:CVS), (NYSE:RAD)
2020-07-09T00:00:00
2020-07-09T00:00:00
42.970001
41.830002
42.939999
43.299999
43.549999
43.610001
44.200001
45.349998
47.02
45.279999
44.279999
40.75
41.400002
41.490002
42.150002
42.150002
41.98
44.130001
43.240002
42.810001
41.169998
42.040001
41.169998
42.32
42.389999
40.880001
41.98
43.16
42.220001
42.290001
39.009998
40.119999
39.580002
40.110001
40.68
41.349998
41.419998
40.459999
40.41
40.689999
40.34
40.509998
39.84
40.68
41.16
40.639999
2020-07-09
WBA
It's tech again as broader market edges higher at the open
Stocks start the session in the green with the familiar refrain of tech and megacaps providing support. The S&P is up 0.3%, the Dow is up 0.1% and the Nasdaq is taking the top spot again, up 0.75%. Microsoft is up 1.6% following a price hike on cloud growth. Amazon, Apple and Alphabet are all gaining. The broader market is seeing weakness from Walgreens (NASDAQ:WBA), off 6.8%, following missed earnings, but sentiment was helped by better-than-expected jobless claims. In commodities, oil futures are sliding 1% and gold futures are dipping 0.1%.
2020-07-10T00:00:00
2020-07-10T00:00:00
41.830002
42.939999
43.299999
43.549999
43.610001
44.200001
45.349998
47.02
45.279999
44.279999
40.75
41.400002
41.490002
42.150002
42.150002
41.98
44.130001
43.240002
42.810001
41.169998
42.040001
41.169998
42.32
42.389999
40.880001
41.98
43.16
42.220001
42.290001
39.009998
40.119999
39.580002
40.110001
40.68
41.349998
41.419998
40.459999
40.41
40.689999
40.34
40.509998
39.84
40.68
41.16
40.639999
40.709999
2020-07-09
WBA
Costco looks more indicative of consumer staples trends than Walgreens
There are mixed fortunes for Consumer Staples stocks as Walgreens and Costco went in different directions.Walgreens (WBA, -5.5%), fell in premarket trading after missing sharply on earnings expectations, citing the COVID impact. It had mixed news for shareholders, boosting its dividend and suspending buybacks, but those looking at operations will be concerned about a plan for 4,000 job cuts.Costco (COST, +1.75%) was higher after seeing comparable sales rising 11.5% in June, easily topping the consensus estimate for a gain of 4.2%.The sector as a whole looks like it’s more encouraged by Costco than disappointed by Walgreens. Walmart (WMT, +1.25%) and Kroger (KR, +0.7%) are joining Costco in positive territory. Walgreens looks like more of the outlier at the bottom of list.The weakness from Walgreens looks not just COVID specific, but also geographically specific.UK drugstore (or chemist) chain Boots was a chief reason for the poor performance, with the company highlighting a “dramatic reduction in footfall” as its beauty and fragrance counters were effectively closed. The company says UK “retail conditions are expected to remain very depressed, despite gradual easing of restrictions,” but Boots was already facing problems ahead of the lockdown. The chain was in a restructuring plan designed to kickstart growth in the UK market that included job cuts and store closures.In its U.S. market, Walgreens reported comparable sales up 3.5% for the quarter, excluding tobacco. The trend to lower-margin items during lockdown restrictions and employment uncertainty isn’t surprising and echoes recent results from Rite Aid (RAD,+0.1%).Demand for vitamins and PPI boosted health and wellness sales 9%, but with people staying indoors, beauty product sales fell 9%. Those should balance out with reopening (although that timeline remains very uncertain). The Consumer Staples sector has been indicating an economic recovery throughout the second quarter. The Consumer Staples Select Sector SPDR Fund (NYSEARCA:XLP) has been underperforming the Consumer Discretionary Select Sector SPDR Fund (NYSEARCA:XLY) since April.Â
2020-07-10T00:00:00
2020-07-10T00:00:00
41.830002
42.939999
43.299999
43.549999
43.610001
44.200001
45.349998
47.02
45.279999
44.279999
40.75
41.400002
41.490002
42.150002
42.150002
41.98
44.130001
43.240002
42.810001
41.169998
42.040001
41.169998
42.32
42.389999
40.880001
41.98
43.16
42.220001
42.290001
39.009998
40.119999
39.580002
40.110001
40.68
41.349998
41.419998
40.459999
40.41
40.689999
40.34
40.509998
39.84
40.68
41.16
40.639999
40.709999
2020-07-09
WBA
Walgreens slips 3% on FQ3 miss, boosts dividend, cuts jobs
Walgreens Boots (NASDAQ:WBA) fiscal Q3 results: Revenues: $34,631M (+0.1%). Net loss: ($1,708M) (-266.6%); loss/share: ($1.95) (+272.6%); non-GAAP Net Income: $723M (-46.0%); non-GAAP EPS: $0.83 (-43.5%). CF Ops (3 months): $914M (-54.8%). Gross margin of 18.9% vs. consensus of 20.3%, adversely impacted by shift from higher to lower margin categories and by higher supply chain costs. Adverse sales impact of ~$700M to $750M, which was almost entirely from the company's non-U.S. businesses. During the quarter, the company partly mitigated the impact of COVID-19 by continuing to curtail costs, including temporary store closures, furloughing more than 16,000 UK employees, decreasing store hours and reducing rents at some locations. Fiscal 2020 guidance: Non-GAAP EPS: $4.65 - 4.75; including estimated COVID-19 impacts of $1.03 to $1.14 per share. In the UK, retail conditions are expected to remain very depressed, despite gradual easing of restrictions. The Company increased quarterly dividend by 2.2% to $0.4675/share. The Company announced job cuts of up to 4,000 positions, about 7% of workforce. Shares are down 3% premarket. Previously: Walgreens Boots EPS misses by $0.39, cutting jobs, suspending buybacks (July 9)
2020-07-10T00:00:00
2020-07-10T00:00:00
41.830002
42.939999
43.299999
43.549999
43.610001
44.200001
45.349998
47.02
45.279999
44.279999
40.75
41.400002
41.490002
42.150002
42.150002
41.98
44.130001
43.240002
42.810001
41.169998
42.040001
41.169998
42.32
42.389999
40.880001
41.98
43.16
42.220001
42.290001
39.009998
40.119999
39.580002
40.110001
40.68
41.349998
41.419998
40.459999
40.41
40.689999
40.34
40.509998
39.84
40.68
41.16
40.639999
40.709999
2020-07-09
WBA
Walgreens Boots raises dividend by 2.2%
Walgreens Boots (NASDAQ:WBA) declares $0.4675/share quarterly dividend, a 2.2% increase from prior dividend of $0.4575. Forward yield 4.42% Payable Sept. 11; for shareholders of record Aug. 19; ex-div Aug. 18. See WBA Dividend Scorecard, Yield Chart, & Dividend Growth.
2020-07-10T00:00:00
2020-07-10T00:00:00
41.830002
42.939999
43.299999
43.549999
43.610001
44.200001
45.349998
47.02
45.279999
44.279999
40.75
41.400002
41.490002
42.150002
42.150002
41.98
44.130001
43.240002
42.810001
41.169998
42.040001
41.169998
42.32
42.389999
40.880001
41.98
43.16
42.220001
42.290001
39.009998
40.119999
39.580002
40.110001
40.68
41.349998
41.419998
40.459999
40.41
40.689999
40.34
40.509998
39.84
40.68
41.16
40.639999
40.709999
2020-07-09
WBA
Walgreens Boots EPS misses by $0.39, cutting jobs, suspending buybacks
Walgreens Boots (NASDAQ:WBA): Q3 Non-GAAP EPS of $0.83 misses by $0.39; GAAP EPS of -$1.95 misses by $2.80. Revenue of $34.63B (+0.1% Y/Y) beats by $310M. Gross margin of 18.9% vs. consensus of 20.3%; Operating margin of 2.3% vs. consensus of 3.7% Company is now targeting cost savings of more than $2B vs. $1.8B previously, by fiscal 2022; sees job cuts of more than 4K, or 7% of workforce. There's a 2.2% boost to the quarterly dividend to $0.4675 per share, but buybacks are put on hold. Shares +0.095% PM. Press Release
2020-07-10T00:00:00
2020-07-10T00:00:00
41.830002
42.939999
43.299999
43.549999
43.610001
44.200001
45.349998
47.02
45.279999
44.279999
40.75
41.400002
41.490002
42.150002
42.150002
41.98
44.130001
43.240002
42.810001
41.169998
42.040001
41.169998
42.32
42.389999
40.880001
41.98
43.16
42.220001
42.290001
39.009998
40.119999
39.580002
40.110001
40.68
41.349998
41.419998
40.459999
40.41
40.689999
40.34
40.509998
39.84
40.68
41.16
40.639999
40.709999
2020-07-08
WBA
Walgreens Boots Q3 2020 Earnings Preview
Walgreens Boots (NASDAQ:WBA) is scheduled to announce Q3 earnings results on Thursday, July 9th, before market open. The consensus EPS Estimate is $1.22 (-17.0% Y/Y) and the consensus Revenue Estimate is $34.32B (-0.8% Y/Y). Over the last 2 years, WBA has beaten EPS estimates 75% of the time and has beaten revenue estimates 50% of the time. Over the last 3 months, EPS estimates have seen 1 upward revision and 14 downward. Revenue estimates have seen 3 upward revisions and 8 downward.
2020-07-09T00:00:00
2020-07-09T00:00:00
42.970001
41.830002
42.939999
43.299999
43.549999
43.610001
44.200001
45.349998
47.02
45.279999
44.279999
40.75
41.400002
41.490002
42.150002
42.150002
41.98
44.130001
43.240002
42.810001
41.169998
42.040001
41.169998
42.32
42.389999
40.880001
41.98
43.16
42.220001
42.290001
39.009998
40.119999
39.580002
40.110001
40.68
41.349998
41.419998
40.459999
40.41
40.689999
40.34
40.509998
39.84
40.68
41.16
40.639999
2020-07-10
WBA
Walgreens discloses meeting with DOJ over alleged violations of Controlled Substances Act
Walgreens Boots Alliance (NASDAQ:WBA) discloses (10-Q, page 24) that the company met with the U.S. Department of Justice (DOJ) last month concerning alleged violations of the U.S. Controlled Substances Act and the U.S. False Claims Act. The inquiry relates to prescription dispensing at certain Walgreens locations.
2020-07-11T00:00:00
2020-07-13T00:00:00
42.939999
43.299999
43.549999
43.610001
44.200001
45.349998
47.02
45.279999
44.279999
40.75
41.400002
41.490002
42.150002
42.150002
41.98
44.130001
43.240002
42.810001
41.169998
42.040001
41.169998
42.32
42.389999
40.880001
41.98
43.16
42.220001
42.290001
39.009998
40.119999
39.580002
40.110001
40.68
41.349998
41.419998
40.459999
40.41
40.689999
40.34
40.509998
39.84
40.68
41.16
40.639999
40.709999
41.080002
2020-07-16
WBA
Walgreens high on DoorDash collaboration
More than 2,300 health, wellness and convenience products will now be delivered on-demand to consumers in Chicago, Atlanta and Denver through the Walgreens (NASDAQ:WBA +1.8%) and DoorDash (DOORD) collaboration. During summer, it seeks to expand to Cincinnati, Cleveland, Minneapolis, Oklahoma City, Phoenix, Sacramento and Seattle. By the end of summer 2020, they plan to offer +5K items for delivery on the DoorDash platform. Walgreens is available on DoorDash's subscription service, DashPass, offering unlimited free delivery fees and reduced service fees to members. Walgreens shares have been sharply lagging the broader market during the market recovery (-25.5% in past 6 months vs. -1.7%). The stocks tumbled last week on disappointing earnings, but has recovered some as investors saw the performance problems concentrated in its Boots UK business. "When considering the forward P/E and price to cash flow ratios, the company currently trades for roughly half the historical valuation. I will add that much of the company’s revenues come from essential items that are immune to pandemic concerns and economic cycles," Chuck Walston wrote on Seeking Alpha this week.
2020-07-17T00:00:00
2020-07-17T00:00:00
44.200001
45.349998
47.02
45.279999
44.279999
40.75
41.400002
41.490002
42.150002
42.150002
41.98
44.130001
43.240002
42.810001
41.169998
42.040001
41.169998
42.32
42.389999
40.880001
41.98
43.16
42.220001
42.290001
39.009998
40.119999
39.580002
40.110001
40.68
41.349998
41.419998
40.459999
40.41
40.689999
40.34
40.509998
39.84
40.68
41.16
40.639999
40.709999
41.080002
40.93
40.810001
40.889999
41.52
2020-07-16
WBA
CVS Pharmacies to require face masks July 20
CVS Health's (NYSE:CVS +0.8%) retail pharmacies will require customers to wear face masks effective Monday, July 20, due to the recent spike in COVID-19 infections. Yesterday, retail behemoth Walmart announced the same, also effective July 20. Update: Walgreens (NASDAQ:WBA +1.3%) has followed suit, requiring face masks in its stores effective July 20.
2020-07-17T00:00:00
2020-07-17T00:00:00
44.200001
45.349998
47.02
45.279999
44.279999
40.75
41.400002
41.490002
42.150002
42.150002
41.98
44.130001
43.240002
42.810001
41.169998
42.040001
41.169998
42.32
42.389999
40.880001
41.98
43.16
42.220001
42.290001
39.009998
40.119999
39.580002
40.110001
40.68
41.349998
41.419998
40.459999
40.41
40.689999
40.34
40.509998
39.84
40.68
41.16
40.639999
40.709999
41.080002
40.93
40.810001
40.889999
41.52
2020-07-17
WBA
Slow turnaround times plague COVID-19 test sites
People using drive-through sample collection sites at U.S. retail pharmacies are having to wait 10 days or longer to receive the results from their COVID-19 nasal swab tests, negating most of the benefits of the testing due to the delay in isolation and contact tracing. CVS (CVS +0.5%), the chain with the most sites, has instructed employees to tell customers to expect 5 - 7 days before receiving results, although the website for MinuteClinic recently changed the time frame to 6 - 10 days due to high demand. The company also instructed workers to convey to customers that turnaround times have been negatively impacted by backlogs at its testing partners. Reference lab Quest Diagnostics (DGX +1.7%) says its average turnaround time is seven or more days due to supply chain constraints. Each CVS drive-through location can process ~50 samples each day or ~70K per day company-wide. Yesterday, a Rockefeller Foundation-backed committee issued a report stating the need for $75B to fix America's "flawed" testing system for the respiratory illness. Related tickers: LH, RAD, WBA, OPK
2020-07-18T00:00:00
2020-07-20T00:00:00
45.349998
47.02
45.279999
44.279999
40.75
41.400002
41.490002
42.150002
42.150002
41.98
44.130001
43.240002
42.810001
41.169998
42.040001
41.169998
42.32
42.389999
40.880001
41.98
43.16
42.220001
42.290001
39.009998
40.119999
39.580002
40.110001
40.68
41.349998
41.419998
40.459999
40.41
40.689999
40.34
40.509998
39.84
40.68
41.16
40.639999
40.709999
41.080002
40.93
40.810001
40.889999
41.52
42.860001
2020-07-20
WBA
Higher targets on these drug distributors from Baird as Q2 season arrives
Looking ahead to Q2 results from drug distributors, Baird is looking for a "relatively shallow Rx divot" and a gradual recovery already under way - expecting that COVID-19 impacts will be "contained" after Q2. And with valuation discount "steep" compared to broader indices, Baird says even with investor interest returning there's still "plenty of time to hop aboard." In core distribution businesses, it's expecting revenues down 1%, though read-throughs from big retail and mail pharmacy point to potentially better results than that. Sector EBIT is expected to decline 10%, with EPS down about 21%, and the firm is expecting upside from consensus for AmerisourceBergen (NYSE:ABC), Cardinal Health (NYSE:CAH) and McKesson (NYSE:MCK). With worst-case scenarios seemingly off the table, there's room for AmerisourceBergen and McKesson to narrow some wider-than-usual full-year guidance. Meanwhile, Cardinal Health's initial 2021 guidance will be the most interesting thing to watch for, with Pharma maybe ready to turn a corner after three bad years (though Medical is still a question mark). Overall in the sector, Baird has its eye on opioids (amid recent news of more bid-ask narrowing on a global settlement); generic pricing (no big change in the past couple of months, but an environment much improved over the last year); and mail pharmacy (after some concern about channel shift, Walgreens (NASDAQ:WBA) and Rite-Aid (NYSE:RAD) show retail is still resilient, and recent IQVIA data shows a slowdown coming back in Mail). The firm is raising its price target on ABC to $122 from $115, implying 19% upside; and it's raising its target on MCK to $200 from $193, suggesting 30% upside. Its target on Cardinal Health remains $65, implying 22% upside.
2020-07-21T00:00:00
2020-07-21T00:00:00
47.02
45.279999
44.279999
40.75
41.400002
41.490002
42.150002
42.150002
41.98
44.130001
43.240002
42.810001
41.169998
42.040001
41.169998
42.32
42.389999
40.880001
41.98
43.16
42.220001
42.290001
39.009998
40.119999
39.580002
40.110001
40.68
41.349998
41.419998
40.459999
40.41
40.689999
40.34
40.509998
39.84
40.68
41.16
40.639999
40.709999
41.080002
40.93
40.810001
40.889999
41.52
42.860001
41.849998
2020-07-27
WBA
Walgreens CEO to slide over to chairman post
Walgreens Boots Alliance (NASDAQ:WBA -2.3%) says CEO Stefano Pessina has decided to step down to become executive chairman of the board after a new CEO is named. Current Executive Chairman James Skinner plans to step down when Pessina moves the chairman post. Skinner will remain on the board. The board of directors is beginning the process of searching for a new CEO. Walgreen's: The CEO exits The shakeup arrives with shares of Walgreens down 33% YTD. Source: Press Release
2020-07-28T00:00:00
2020-07-28T00:00:00
41.490002
42.150002
42.150002
41.98
44.130001
43.240002
42.810001
41.169998
42.040001
41.169998
42.32
42.389999
40.880001
41.98
43.16
42.220001
42.290001
39.009998
40.119999
39.580002
40.110001
40.68
41.349998
41.419998
40.459999
40.41
40.689999
40.34
40.509998
39.84
40.68
41.16
40.639999
40.709999
41.080002
40.93
40.810001
40.889999
41.52
42.860001
41.849998
41.82
41
41.91
41.18
40.759998
2020-08-25
WBA
Don’t cry for 3 Dow Jones leavers; stocks tend to hold up
Being replaced in the Dow may just amount to a bruised ego.Exxon Mobil (XOM, -2.9%), Raytheon (RTX, -3.1%) and Pfizer (PFE, -1.6%) are all struggling today as the stocks were shown the door from the Dow Jones Industrial Average.The general thinking is that the stocks will lose the support of money indexed or benchmarked to the Dow. It’s more likely just a knee-jerk reaction to a negative headline, though. Yes, there is $28B indexed to the Dow 30. But there’s $11.2T indexed and benchmarked to the S&P, with index funds making up $4.6T.In fact, the effect of losing Dow status may just be hurt pride. Looking further down the road, getting jettisoned from the index doesn’t seem to have much impact on shares.Of the 17 stocks that have been removed from the Dow since 1999, the average one-year performance is down less than 1%, according to WSJ Market Data Group calculated in mid-2018.The last big Dow reshuffle in 2013 saw Alcoa (AA, -1.5%), Bank of America (BAC, +0.8%) and Hewlett-Packard leave. A year later, Alcoa was up 96%, BofA was up 17% and HP was up 73%.How did Exxon, Pfizer and Raytheon get the boot? The main reason is that S&P Dow Jones Indices wants to pivot the index more to tech and it would be losing a lot of that exposure after Apple’s stock split, since the Dow is a price-weighted index.Exxon has been a member of the index since 1928. But over the last 10 years, Exxon is down 28.4%, compared with fellow Dow member Chevron, up 18.2%. Looking at total return, Exxon is up just 2.3%, with Chevron up 73.7%.Pfizer has performed about the same as fellow component Merck (MRK, -0.1%) in the last 10 years, both up about 250%. Replacement Amgen (AMGN, +4%) is up 466%. But in the last five years, Merck, up 94%, has nearly doubled the performance of Pfizer, up 49%.Raytheon is simply not the company is was when it was just United Technologies, with much more aerospace exposure, already featuring in the index with Boeing (BA, -2.8%). Honeywell (HON, +3%), ousted in 2008, brings back more of the pure industrial business.Investors should perhaps be more concerned about the shares of new entries. According to the same data cited earlier, the 17 new entrants since 1999 fell 8% on average a year after their Dow debut. Walgreens (WBA, -1.4%) is down 42% since it entered the index in 2018.
2020-08-26T00:00:00
2020-08-26T00:00:00
40.68
41.349998
41.419998
40.459999
40.41
40.689999
40.34
40.509998
39.84
40.68
41.16
40.639999
40.709999
41.080002
40.93
40.810001
40.889999
41.52
42.860001
41.849998
41.82
41
41.91
41.18
40.759998
40.25
39.709999
39.459999
39.740002
39.5
38.669998
39.34
38.759998
38.02
36.759998
37.169998
37.09
36.889999
36.099998
35.349998
34.669998
34.700001
35.110001
35.27
36.279999
37.209999
2020-08-31
WBA
Walgreens picks former Rite Aid CEO Standley to lead operations
Walgreens Boots Alliance (NASDAQ:WBA) appoints former Rite Aid Chairman and CEO John Standley as President of Walgreens, effective immediately. Standley replaces Alex Gourlay, who will return to his co-COO role at Walgreens Boots Alliance. Standley left Rite Aid last year following two failed merger attempts and a battered stock price. The hiring comes just a month after CEO Stefano Pessina announced his decision to step down to become Executive Chairman after a new CEO is named.
2020-09-01T00:00:00
2020-09-01T00:00:00
40.41
40.689999
40.34
40.509998
39.84
40.68
41.16
40.639999
40.709999
41.080002
40.93
40.810001
40.889999
41.52
42.860001
41.849998
41.82
41
41.91
41.18
40.759998
40.25
39.709999
39.459999
39.740002
39.5
38.669998
39.34
38.759998
38.02
36.759998
37.169998
37.09
36.889999
36.099998
35.349998
34.669998
34.700001
35.110001
35.27
36.279999
37.209999
36.93
35.790001
35.720001
35.060001
2020-08-31
WBA
Original Dow component GE takes a sell-side hit: At the Open
As the Dow Jones Industrial Average is set to trade with three new components, one of its original components is taking a hit from Wall Street.The Dow will trade with Salesforce (CRM, -0.1%), Amgen (AMGN, +0.2%) and Honeywell (HON, +0.7%) in the index. Index stalwart Exxon Mobil (XOM, +0.7%), Pfizer (PFE, +0.3%) and Raytheon (RTX, +0.1%).The new divisor will change to 0.152 from around 0.147, meaning a $1 price move in any Dow component translates to a swing of 6.579 points from around 6.8 points. Dow futures are up about 0.2%.But GE (GE, -1.2%), one of the original 12 Dow components, is struggling, today, though, after negative comments from J.P. Morgan, which also withdrew its price target on the stock.In a note entitled "No Reset, No Consensus Capitulation, No Bottom Yet; With Further Downside Risk, We Are Withdrawing Our PT", J.P. Morgan analysts Stephen Tusa criticized GE’s lack of guidance."We are more negative on GE as we turn the corner into 2H20,” Tusa said. “GE continues to have no official guidance, which in our view implies difficulty seeing 3-6 months out”.While withdrawing the price target and keeping a Neutral rating, Tusa said fair value for the shares is likely below $5. They closed at $6.61 on Friday.GE shares are up just 8% from the March lows and are down 42% year to date. That compared with a year-to-date loss of 4% in the SPDR Industrial Sector ETF (NYSEARCA:XLI).GE shares are very close, though, to breaking above their 50- and 100-day simple moving averages. GE was ousted from the Dow in June 2018, replaced by Walgreens Boots Alliance (WBA, -0.3%). Since then, GE has fallen 46% and Walgreens is down 42%.But GE may have an advantage that can support the stock price ahead.“In recent years, investor concern about GE's residual long-term care liabilities has weighed heavily on the stock price,” Adam Levine-Weinberg wrote on Seeking Alpha. “However, the COVID-19 pandemic may be triggering a change in policyholder behavior that could decisively alter the narrative and reduce the likelihood that investors will get nasty surprises from the run-off insurance business in the future.”For those scoring at home, the original Dow components, along with GE, were American Cotton Oil, American Sugar, American Tobacco, Chicago Gas, Distilling & Cattle Feeding, Laclede Gas, National Lead, North American, Tennessee Coal and Iron, U.S. Leather and U.S. Rubber.Sector WatchZoom Video (ZM, +1.3%) will report earnings after the bell today.The consensus EPS Estimate is $0.45 (+462.5% Y/Y) and the consensus Revenue Estimate is $500.35M (+243.1% Y/Y).See how Zoom has done with respect to other work-from-home stocks.See more market-moving events in Seeking Alpha’s Catalyst Watch.Â
2020-09-01T00:00:00
2020-09-01T00:00:00
40.41
40.689999
40.34
40.509998
39.84
40.68
41.16
40.639999
40.709999
41.080002
40.93
40.810001
40.889999
41.52
42.860001
41.849998
41.82
41
41.91
41.18
40.759998
40.25
39.709999
39.459999
39.740002
39.5
38.669998
39.34
38.759998
38.02
36.759998
37.169998
37.09
36.889999
36.099998
35.349998
34.669998
34.700001
35.110001
35.27
36.279999
37.209999
36.93
35.790001
35.720001
35.060001
2020-09-17
WBA
Walgreens launches Test & Protect program
Walgreens (NASDAQ:WBA) launches Walgreens Test & Protect program with an aim to increase testing capacity to allow for more than 500,000 tests per month, including results provided within 24 to 72 hours. The program will also provide businesses and universities with clinical guidance to aid in their work plans and strategies, including ongoing preventive care services such as flu and other Centers for Disease Control and Prevention-recommended immunizations.
2020-09-18T00:00:00
2020-09-18T00:00:00
40.889999
41.52
42.860001
41.849998
41.82
41
41.91
41.18
40.759998
40.25
39.709999
39.459999
39.740002
39.5
38.669998
39.34
38.759998
38.02
36.759998
37.169998
37.09
36.889999
36.099998
35.349998
34.669998
34.700001
35.110001
35.27
36.279999
37.209999
36.93
35.790001
35.720001
35.060001
35.029999
35.43
36.07
35.380001
35.919998
35.869999
35.77
36.619999
35.950001
36.490002
37.07
36.34
2020-10-12
WBA
Q3 earnings ringing in; FactSet sees drop in earnings across sectors
It is that time of the year again, Wall Street's Q3 earnings season takes off with initial focus on major U.S. banks reporting earnings. S&P 500 Q3 earnings look bad, but not as bad as Q2: Quick look at past 6-months performance of broader sector indices: Johnson & Johnson (NYSE:JNJ), United Airlines (NASDAQ:UAL), Delta Air Lines (NYSE:DAL), Walgreens (NASDAQ:WBA) and UnitedHealth Group (NYSE:UNH) are some other names slated for release this week. As per FactSet data, Q3 S&P 500 earnings are estimated to drop by 20.5% Y/Y as pandemic dents majority of the industries. Led by the Energy, Industrials, and Consumer Discretionary sectors, all the eleven sectors are seen reporting a Y/Y dip in earnings. Quick look index revenue growth estimates: Sales growth is seen edging down by 3.5% Y/Y; however, healthcare is estimated to report annualized earnings growth, while consumer discretionary sector is likely to report flat Y/Y revenue growth. Highlighting the sector and being the Street's favorite is Technology, with chipmakers leading the rally; Information Technology is seen dropping 2.6% in earnings, the least decline across sectors. With five of the 13 sub-industries reporting higher earnings, Semiconductor Equipment group is anticipated to see a  43.1% growth; Systems Software segment earnings to rise ~13% Y/Y. Positive: Of the 22 companies that have already reported earnings, 20 have raced analyst estimates by a wide margin of 25%, as per Earnings Scout. He adds that this is ahead of historical averages wherein companies beat estimates by 3-5%. A few that reported earnings: Darden (NYSE:DRI), FedEx (NYSE:FDX), CarMax (NYSE:KMX), Lennar (NYSE:LEN), AutoZone (NYSE:AZO), and Nike (NYSE:NKE), Domino's Pizza (NYSE:DPZ) "Very rarely in the last 10 years have we seen earnings estimates moving higher after a quarterly reporting season," Art Hogan, chief market strategist at National Securities commented.
2020-10-13T00:00:00
2020-10-13T00:00:00
38.02
36.759998
37.169998
37.09
36.889999
36.099998
35.349998
34.669998
34.700001
35.110001
35.27
36.279999
37.209999
36.93
35.790001
35.720001
35.060001
35.029999
35.43
36.07
35.380001
35.919998
35.869999
35.77
36.619999
35.950001
36.490002
37.07
36.34
36.93
36.18
35.91
37.639999
37.41
36.970001
37.490002
37.389999
37.509998
38.040001
37.209999
36
34.59
33.52
34.040001
35.790001
37.369999
2020-10-15
WBA
Walgreens +2% after earnings topper, solid guidance update
Walgreens Boots Alliance (NASDAQ:WBA) reports sales were up 2.3% in Q4 on both a reported and constant currency basis. Adjusted operating income fell 27.7% to $1.1B during the quarter. The company estimates adverse COVID-19 impact of approximately $520M. CEO update: "We are seeing gradual improvement in key U.S. and UK markets and continued strong performance in our wholesale business. I'm also encouraged by the accelerating growth in our e-commerce platforms. Now, more than ever, our pharmacy-centered business is at the heart of community healthcare and we are expanding on that role for the future." Looking ahead, Walgreens introduces FY21 guidance of low-single digit growth in adjusted earnings per share at constant currency rates vs. the +2.6% consensus mark. Significant investments in FY21 are expected to accelerate WBA's customer-centric approach, with specific focus on transforming omnichannel capabilities and offerings across retail and healthcare. The investments are expected to contribute to the second-half growth profile, although the evolution of the pandemic remains uncertain. Shares of Walgreens are up 2.81% premarket to $36.92. Previously: Walgreens Boots EPS beats by $0.06, beats on revenue (Oct. 15)
2020-10-16T00:00:00
2020-10-16T00:00:00
37.09
36.889999
36.099998
35.349998
34.669998
34.700001
35.110001
35.27
36.279999
37.209999
36.93
35.790001
35.720001
35.060001
35.029999
35.43
36.07
35.380001
35.919998
35.869999
35.77
36.619999
35.950001
36.490002
37.07
36.34
36.93
36.18
35.91
37.639999
37.41
36.970001
37.490002
37.389999
37.509998
38.040001
37.209999
36
34.59
33.52
34.040001
35.790001
37.369999
36.299999
37.529999
37.310001
2020-10-15
WBA
Walgreens Boots EPS beats by $0.06, beats on revenue
Walgreens Boots (NASDAQ:WBA): FQ4 Non-GAAP EPS of $1.02 beats by $0.06; GAAP EPS of $0.43 misses by $0.28. Revenue of $34.75B (+2.4% Y/Y) beats by $390M. Gross margin rate 20.2% vs. consensus of 19.5%; Operating margin rate 3.3% vs. consensus of 3.2%. Shares +0.5% PM. Press Release
2020-10-16T00:00:00
2020-10-16T00:00:00
37.09
36.889999
36.099998
35.349998
34.669998
34.700001
35.110001
35.27
36.279999
37.209999
36.93
35.790001
35.720001
35.060001
35.029999
35.43
36.07
35.380001
35.919998
35.869999
35.77
36.619999
35.950001
36.490002
37.07
36.34
36.93
36.18
35.91
37.639999
37.41
36.970001
37.490002
37.389999
37.509998
38.040001
37.209999
36
34.59
33.52
34.040001
35.790001
37.369999
36.299999
37.529999
37.310001
2020-10-14
WBA
Walgreens Boots Q4 2020 Earnings Preview
Walgreens Boots (NASDAQ:WBA) is scheduled to announce Q4 earnings results on Thursday, October 15th, before market open. The consensus EPS Estimate is $0.96 (-32.9% Y/Y) and the consensus Revenue Estimate is $34.36B (+1.2% Y/Y). Analysts expect Gross margin of 19.5%; and Operating margin of 3.2%. Over the last 2 years, WBA has beaten EPS estimates 63% of the time and has beaten revenue estimates 50% of the time. Over the last 3 months, EPS estimates have seen 2 upward revisions and 13 downward. Revenue estimates have seen 3 upward revisions and 7 downward.
2020-10-15T00:00:00
2020-10-15T00:00:00
37.169998
37.09
36.889999
36.099998
35.349998
34.669998
34.700001
35.110001
35.27
36.279999
37.209999
36.93
35.790001
35.720001
35.060001
35.029999
35.43
36.07
35.380001
35.919998
35.869999
35.77
36.619999
35.950001
36.490002
37.07
36.34
36.93
36.18
35.91
37.639999
37.41
36.970001
37.490002
37.389999
37.509998
38.040001
37.209999
36
34.59
33.52
34.040001
35.790001
37.369999
36.299999
37.529999
2020-10-16
WBA
CVS confirms providing future COVID vaccine for long-term care (update)
Update: CVS confirms deal to provide future vaccine to long-term care facilities. "CVS Health is already providing 70 percent of the testing done in a retail setting through its test sites at 3,700 of its drive thru pharmacies," CEO Larry Merlo says. "Moving forward we'll have the capacity to administer approximately four million COVID-19 tests per month to meet the nation's needs ahead of a vaccine approval." CVS +0.5%, Walgreens -0.4% ##### The White House will announce a deal for CVS (NYSE:CVS) and Walgreens (NASDAQ:WBA) to administer a COVID-19 vaccine to seniors and staff in long-term care facilities later today, Politico reports. President Trump is expected to announce the deal at a Florida speech this afternoon. The plan could still change, Politico says, citing a source. Pfizer CEO Albert Bourla said the company could be ready to apply for emergency-use authorization of its COVID-19 vaccine by late November.
2020-10-17T00:00:00
2020-10-19T00:00:00
36.889999
36.099998
35.349998
34.669998
34.700001
35.110001
35.27
36.279999
37.209999
36.93
35.790001
35.720001
35.060001
35.029999
35.43
36.07
35.380001
35.919998
35.869999
35.77
36.619999
35.950001
36.490002
37.07
36.34
36.93
36.18
35.91
37.639999
37.41
36.970001
37.490002
37.389999
37.509998
38.040001
37.209999
36
34.59
33.52
34.040001
35.790001
37.369999
36.299999
37.529999
37.310001
39.779999
2020-10-29
WBA
Walgreens Boots declares $0.4675 dividend
Walgreens Boots (NASDAQ:WBA) declares $0.4675/share quarterly dividend, in line with previous. Forward yield 5.57% Payable Dec. 11; for shareholders of record Nov. 19; ex-div Nov. 18. See WBA Dividend Scorecard, Yield Chart, & Dividend Growth.
2020-10-30T00:00:00
2020-10-30T00:00:00
36.93
35.790001
35.720001
35.060001
35.029999
35.43
36.07
35.380001
35.919998
35.869999
35.77
36.619999
35.950001
36.490002
37.07
36.34
36.93
36.18
35.91
37.639999
37.41
36.970001
37.490002
37.389999
37.509998
38.040001
37.209999
36
34.59
33.52
34.040001
35.790001
37.369999
36.299999
37.529999
37.310001
39.779999
42.349998
41.439999
40.77
42.709999
44.099998
39.849998
38.23
37.849998
37.529999
2020-11-02
WBA
Walgreens Boots and McKesson complete German joint venture
Walgreens Boots Alliance (NASDAQ:WBA) and McKesson (NYSE:MCK) complete their previous agreement to create a joint venture (JV) combining respective pharmaceutical wholesale businesses in Germany, Alliance Healthcare Deutschland and GEHE Pharma Handel. WBA holds a 70% controlling interest in the JV while McKesson holds the remaining 30%. Walgreens recently reported its consensus beating FQ4, with 2.3% rise in sales, gross margin rate of 20.2% and operating margin of 3.3%. Previously: Walgreens Boots Alliance and McKesson team up in Germany (Dec. 12, 2019)
2020-11-03T00:00:00
2020-11-03T00:00:00
35.720001
35.060001
35.029999
35.43
36.07
35.380001
35.919998
35.869999
35.77
36.619999
35.950001
36.490002
37.07
36.34
36.93
36.18
35.91
37.639999
37.41
36.970001
37.490002
37.389999
37.509998
38.040001
37.209999
36
34.59
33.52
34.040001
35.790001
37.369999
36.299999
37.529999
37.310001
39.779999
42.349998
41.439999
40.77
42.709999
44.099998
39.849998
38.23
37.849998
37.529999
37.98
38.52
2020-11-17
WBA
CVS, Walgreens, and Rite Aid are all tumbling after Amazon's Pharmacy launch
The move by Amazon may have been anticipated for a while, but - at least for now - it wasn't fully priced in to brick-and-mortar pharmacy players. CVS (NYSE:CVS) is down 6.4%, Walgreens (NASDAQ:WBA) 10%, and Rite Aid (NYSE:RAD) 9.8% premarket. There's also drug distribution names like Cardinal Health (NYSE:CAH), which is lower by 2.5%, McKesson (NYSE:MCK) down 2.3%, and AmerisourceBergen (NYSE:ABC) off 1.1%. And don't forget recently gone-public online drug comparison player GoodRx (NASDAQ:GDRX), down 16.6% premarket.
2020-11-18T00:00:00
2020-11-18T00:00:00
36.490002
37.07
36.34
36.93
36.18
35.91
37.639999
37.41
36.970001
37.490002
37.389999
37.509998
38.040001
37.209999
36
34.59
33.52
34.040001
35.790001
37.369999
36.299999
37.529999
37.310001
39.779999
42.349998
41.439999
40.77
42.709999
44.099998
39.849998
38.23
37.849998
37.529999
37.98
38.52
39.07
39
38.009998
38.459999
39.84
42.82
43.41
42.43
41.990002
41.77
41.650002
2020-11-17
WBA
Amazon makes waves with launch of pharmacy business
Amazon's (NASDAQ:AMZN) move had been anticipated for quite a while, given the many reported internal discussions and acquisition of PillPack in 2018, but the latest news is likely to shake CVS (NYSE:CVS), Walmart (NYSE:WMT), Rite Aid (NYSE:RAD) and Walgreens (NASDAQ:WBA). Amazon Pharmacy will allow customers in the U.S. to order prescription medications for home delivery, including free delivery for Amazon Prime members. It's great timing for a launch as Americans are increasingly relying on getting their medicines via mail to avoid getting exposed to COVID-19, and that shift may become permanent. Amazon Pharmacy will accept most forms of insurance, but could offer savings for people without insurance as well, while customers can also use flexible spending accounts or health savings accounts to buy prescriptions. How will it work? Doctors can send prescriptions directly to Amazon Pharmacy - which has tools to verify that a physician legitimately ordered each prescription - or patients can request a transfer from existing retailers. Customers over the age of 18 will have access to the pharmacy service this week in 45 states. Hawaii, Illinois, Kentucky, Louisiana and Minnesota are not yet included. Amazon Prime customers get free two-day delivery (shipping may still take up to five days the first time a customer orders, as it takes time to transfer a medication). Customers who don’t have Prime can get free delivery within five days, or they can pay $5.99 to upgrade to two-day delivery.
2020-11-18T00:00:00
2020-11-18T00:00:00
36.490002
37.07
36.34
36.93
36.18
35.91
37.639999
37.41
36.970001
37.490002
37.389999
37.509998
38.040001
37.209999
36
34.59
33.52
34.040001
35.790001
37.369999
36.299999
37.529999
37.310001
39.779999
42.349998
41.439999
40.77
42.709999
44.099998
39.849998
38.23
37.849998
37.529999
37.98
38.52
39.07
39
38.009998
38.459999
39.84
42.82
43.41
42.43
41.990002
41.77
41.650002
2020-11-20
WBA
Holiday season online shopping traffic increases 82% in the first week of November
According to the Verizon Business Retail Trends Report, online retailers are booming as COVID-19 restrictions led to an increase in online shopping this holiday season. As per the National Retail Federation (NRF) first week of November 2020 shows 82% Y/Y increase in data traffic. 20% fewer people are moving to and around malls vs. last year and 59% more people visiting malls since the height of COVID-19 restrictions which led to 28% Y/Y increase in use on payment sites. Michele Dupre, VP of Sales Vertical Markets, Retail and Hospitality for Verizon Business said, "Online retailers will need to continue to invest in creative and innovative customer experiences, to capture revenue and offset lost sales from in-person shopping.” Deloitte also forecasts that e-commerce sales will grow by 25% to 35%, Y/Y during the 2020-2021 holiday season vs. sales growth of 14.7% in 2019. E-commerce holiday sales are expected to generate between $182B-$196B this season. Sector Watch: Walmart (NYSE:WMT), Amazon (NASDAQ:AMZN), eBay (NASDAQ:EBAY), The Kroger (NYSE:KR), Costco (NASDAQ:COST), Walgreens Boots Alliance (NASDAQ:WBA), Target (NYSE:TGT) Home Depot (NYSE:HD), Etsy (NASDAQ:ETSY) and Lowe's (NYSE:LOW). Retail ETFs: (NYSEARCA:XLY), (NYSEARCA:XRT), (NYSEARCA:VCR), (NYSEARCA:FDIS),(NASDAQ:RTH), (NYSEARCA:RETL), (NYSEARCA:EMTY), (NYSEARCA:WANT), (NYSEARCA:FXD), (NYSEARCA:RCD), (NYSEARCA:JHMC), (NASDAQ:FTXD).
2020-11-21T00:00:00
2020-11-23T00:00:00
36.93
36.18
35.91
37.639999
37.41
36.970001
37.490002
37.389999
37.509998
38.040001
37.209999
36
34.59
33.52
34.040001
35.790001
37.369999
36.299999
37.529999
37.310001
39.779999
42.349998
41.439999
40.77
42.709999
44.099998
39.849998
38.23
37.849998
37.529999
37.98
38.52
39.07
39
38.009998
38.459999
39.84
42.82
43.41
42.43
41.990002
41.77
41.650002
41.529999
41.48
41.330002
2020-12-02
WBA
Walgreens to open 40 full-service Village Medical primary care clinics
Walgreens' (NASDAQ:WBA +3.5%) Boots Alliance and VillageMD plan to open the next 40 new Village Medical at Walgreens full-service primary care clinics by the end of summer 2021. Initial markets targeted for expansion are Houston, El Paso and Austin, Texas, Phoenix, Ariz., and Orlando, Fla. The first new locations outside of Houston will open in the Phoenix area commencing Dec. 14, 2020. Expansion is part of the large-scale rollout announced earlier this year to open 500 to 700 Village Medical at Walgreens clinics in more than 30 U.S. markets in the upcoming five years. With the combined expertise of both the physician and pharmacist, patients benefit from improved health outcomes and lowered cost of care.
2020-12-03T00:00:00
2020-12-03T00:00:00
37.389999
37.509998
38.040001
37.209999
36
34.59
33.52
34.040001
35.790001
37.369999
36.299999
37.529999
37.310001
39.779999
42.349998
41.439999
40.77
42.709999
44.099998
39.849998
38.23
37.849998
37.529999
37.98
38.52
39.07
39
38.009998
38.459999
39.84
42.82
43.41
42.43
41.990002
41.77
41.650002
41.529999
41.48
41.330002
40.439999
40.880001
40.689999
40.669998
39.27
39.869999
39.619999
2020-12-03
WBA
U.S. could immunize one-third of population within three months
The U.S. should be able to distribute enough coronavirus vaccines from Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) to immunize 100M people by the end of February, which would protect the elderly, healthcare workers and people with pre-existing conditions. There could even be more doses than expected if Johnson & Johnson's (NYSE:JNJ) potential vaccine is authorized before then, according to Dr. Moncef Slaoui, who is leading the Trump administration's vaccine program Operation Warp Speed. CVS (NYSE:CVS) and Walgreens (NASDAQ:WBA) are gearing up to deliver most of the vaccine doses for the nation's approximately 15,600 nursing homes and 29,000 assisted-living communities, but the effort will need to navigate rollout details that may vary by state. Grim milestone... More than 100,000 people are currently sick with coronavirus in hospitals across the U.S., pushing healthcare workers to their limits.
2020-12-04T00:00:00
2020-12-04T00:00:00
37.509998
38.040001
37.209999
36
34.59
33.52
34.040001
35.790001
37.369999
36.299999
37.529999
37.310001
39.779999
42.349998
41.439999
40.77
42.709999
44.099998
39.849998
38.23
37.849998
37.529999
37.98
38.52
39.07
39
38.009998
38.459999
39.84
42.82
43.41
42.43
41.990002
41.77
41.650002
41.529999
41.48
41.330002
40.439999
40.880001
40.689999
40.669998
39.27
39.869999
39.619999
39.66
2020-12-15
WBA
COVID-19 vaccines expected in drugstores like CVS, Walgreens, and Costco by early spring
Healthcare workers across the U.S. received the first doses of Pfizer's vaccine on Monday. But it will be months before the average person can access these shots at their local drugstore or grocery store. Walgreens Boots (NASDAQ:WBA) and CVS Health (NYSE:CVS) expect to give vaccines to the general public starting in the early spring, executives told CNBC. “Over the next couple of months we anticipate that we’ll be able to have (it in) our stores similar to the flu season,” Rina Shah, group vice president of pharmacy operations at Walgreens, said Monday on CNBC. She said that would be “hopefully in the spring timeframe.” Chris Cox, a senior vice president of CVS, said he hopes the company can give the vaccine at its drugstores “somewhere in the April/May timeframe.” Nearly 20 drugstores and grocers partnered with the U.S. Department of Health and Human Services in mid-November to help administer COVID-19 vaccines. Walgreens and CVS will also play a central role in an early phase of the vaccine rollout. Costco (NASDAQ:COST) is also planning to offer COVID-19 vaccinations to the general public at its in-store pharmacies around early spring, CEO Craig Jelinek said. Rite Aid (NYSE:RAD), Kroger (NYSE:KR), Publix and H-E-B are still waiting to hear when they will receive vaccine doses and can begin offering the shots. The vaccine from Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), which requires two doses, is the first to receive emergency approval from the FDA. By the spring, however, public health officials anticipate vaccines from multiple manufacturers to be available. Moderna’s (NASDAQ:MRNA) vaccine, which also requires two doses, could get the greenlight from the FDA later this week. The U.S. could immunize one-third of population within three months.
2020-12-16T00:00:00
2020-12-16T00:00:00
37.369999
36.299999
37.529999
37.310001
39.779999
42.349998
41.439999
40.77
42.709999
44.099998
39.849998
38.23
37.849998
37.529999
37.98
38.52
39.07
39
38.009998
38.459999
39.84
42.82
43.41
42.43
41.990002
41.77
41.650002
41.529999
41.48
41.330002
40.439999
40.880001
40.689999
40.669998
39.27
39.869999
39.619999
39.66
39.41
39.34
39.880001
41.400002
41.16
43.029999
45.259998
45.209999
2020-12-16
WBA
Verizon Business collaborates with Walgreens Boots Alliance to power digital customer experiences
Verizon (NYSE:VZ) will deploy their Network as a Service (NaaS), an all-encompassing solution to deliver an enhanced customer experience to more than 9,000 Walgreens (NASDAQ:WBA) and Duane Reade retail locations across the US. “This is the largest, fully customized, Network as a Service solution for a partner on this scale,” said Tami Erwin, Chief Executive Officer, Verizon Business. “Working closely with Walgreens to understand their focus areas, we’ve tailored an offering that will meet their technology needs of today, and quickly scale to offer a rolling deployment of 5G in Walgreens locations, next-gen in-store experiences for customers and employees, and future-proofed backend operations to enhance efficiencies.” “WBA’s digital transformation is focused on modernizing and digitizing our company to provide customers with seamless and personalized shopping experiences, whether in-store, online or in the palm of their hand,” said Mike Maresca, Global Chief Technology Officer, Walgreens Boots Alliance. “We continue to enhance our business systems and processes both internally and with industry-leading partners to meet the changing needs of Walgreens customers and boost productivity across our workforce. Verizon’s 20 years of experience in this space will help transform our network in the US and also serve as a foundation for our future digital innovations.”
2020-12-17T00:00:00
2020-12-17T00:00:00
36.299999
37.529999
37.310001
39.779999
42.349998
41.439999
40.77
42.709999
44.099998
39.849998
38.23
37.849998
37.529999
37.98
38.52
39.07
39
38.009998
38.459999
39.84
42.82
43.41
42.43
41.990002
41.77
41.650002
41.529999
41.48
41.330002
40.439999
40.880001
40.689999
40.669998
39.27
39.869999
39.619999
39.66
39.41
39.34
39.880001
41.400002
41.16
43.029999
45.259998
45.209999
47.700001
2020-12-16
WBA
Most of American public may get vaccine by end of February - HHS Secretary Azar
The time frame in which most Americans will be eligible for a coronavirus vaccine keeps moving up. Just two weeks ago, Dr. Moncef Slaoui, head of Operation Warp Speed, said the U.S. could immunize one-third of its population within three months, but it now looks like most of America could get a vaccine by that date. "Depending on the decisions by our governors... but I believe we'll have enough supply out there to be reaching out to the general public for administration - at your CVS (NYSE:CVS), Walgreens (NASDAQ:WBA), Kroegers (NYSE:KR) - by the end of February into March," said Health and Human Services Secretary Alex Azar. That timeline could be even earlier if the approval of the AstraZeneca (NASDAQ:AZN) and Johnson & Johnson (NYSE:JNJ) vaccine comes soon, he added. On Tuesday, the FDA said that that a jab developed by Moderna (NASDAQ:MRNA) was "highly effective," setting the stage for an emergency authorization later this week. (NYSE:PFE) and BioNTech (NASDAQ:BNTX) began shipping their vaccine nationwide on Sunday. Looking to the stocks, Shock Exchange writes today on Seeking Alpha that Moderna's COVID-19 upside looks priced in.
2020-12-17T00:00:00
2020-12-17T00:00:00
36.299999
37.529999
37.310001
39.779999
42.349998
41.439999
40.77
42.709999
44.099998
39.849998
38.23
37.849998
37.529999
37.98
38.52
39.07
39
38.009998
38.459999
39.84
42.82
43.41
42.43
41.990002
41.77
41.650002
41.529999
41.48
41.330002
40.439999
40.880001
40.689999
40.669998
39.27
39.869999
39.619999
39.66
39.41
39.34
39.880001
41.400002
41.16
43.029999
45.259998
45.209999
47.700001
2020-12-18
WBA
Pfizer/ BioNTech COVID-19 vaccine rollout reaches long-term care facilities
Walgreens Boots Alliance (NASDAQ:WBA) announced today the company has started the administration of the COVID-19 vaccine from Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) to residents and staff at long-term care facilities. As part of the CDC's Pharmacy Partnership for Long-term Care Program, the pharmacists will begin the vaccinations at nursing homes and assisted living facilities in Ohio and Connecticut, the company said. With vaccinations in approximately 800 long-term care facilities across 12 states from next week, the company intends to expand the program to nearly 3M residents and staff at 35,000 long-term care facilities as the states finalize their distribution plans and receive the vaccine shipments. Last week, the mRNA-based vaccine from Pfizer and BioNTech became the first to receive the emergency use authorization from the FDA.
2020-12-19T00:00:00
2020-12-21T00:00:00
37.310001
39.779999
42.349998
41.439999
40.77
42.709999
44.099998
39.849998
38.23
37.849998
37.529999
37.98
38.52
39.07
39
38.009998
38.459999
39.84
42.82
43.41
42.43
41.990002
41.77
41.650002
41.529999
41.48
41.330002
40.439999
40.880001
40.689999
40.669998
39.27
39.869999
39.619999
39.66
39.41
39.34
39.880001
41.400002
41.16
43.029999
45.259998
45.209999
47.700001
47.959999
48.939999
2020-12-30
WBA
U.S. vaccinations far short of 'Warp Speed' target for 2020
With only two days remaining in 2020, the U.S. will likely fall short of its goal to vaccinate 20M Americans by the year's end. Operation Warp Speed planned to provide 40M doses (each vaccine requires two shots) between Pfizer-BioNTech (PFE, BNTX) and Moderna (NASDAQ:MRNA), but according to the latest figures from the CDC, just more than 11.4M doses had been distributed since Dec. 13 and only about 2.1M had been administered (the large variance is partly due to a lag in reporting). What's going on? COVID-19 vaccine czar, Moncef Slaoui, acknowledged last week that the ramp-up of immunizations "is slower than we thought it would be," while U.S. Army Gen. Gustave Perna, who oversees logistics for Operation Warp Speed, repeatedly apologized after some state officials reported cuts to their allocations. The launch of the federal government's partnership with major pharmacy chains like CVS (NYSE:CVS) and Walgreens (NASDAQ:WBA), which will be tasked with vaccinating long-term care residents, is also pending. "I believe that as we get into January, we are going to see an increase in the momentum," Dr. Anthony Fauci told CNN, adding that he hopes the push will be enough to "catch up to the projected pace that we had spoken about a month or two ago." "The Trump administration’s plan to distribute vaccines is falling behind, far behind," President-elect Joe Biden added at news briefing. He said his administration would "move heaven and earth" to accelerate distribution once he takes office on Jan. 20. The situation is even more imperative after the U.S. confirmed the first case of a new and potentially more infectious strain of COVID-19 recently discovered in U.K. The individual is a male in his 20s, who is currently in isolation in Elbert County, Colorado, but does not have a travel history. In other coronavirus news, a vaccine being developed by the University of Oxford and AstraZeneca (NASDAQ:AZN) was just authorized for emergency use in the U.K., though Moncef Slaoui and others in the U.S. have expressed concern over the age groups in the trial.
2020-12-31T00:00:00
2020-12-31T00:00:00
39.849998
38.23
37.849998
37.529999
37.98
38.52
39.07
39
38.009998
38.459999
39.84
42.82
43.41
42.43
41.990002
41.77
41.650002
41.529999
41.48
41.330002
40.439999
40.880001
40.689999
40.669998
39.27
39.869999
39.619999
39.66
39.41
39.34
39.880001
41.400002
41.16
43.029999
45.259998
45.209999
47.700001
47.959999
48.939999
49.32
48.919998
48.150002
48.09
47.07
47.450001
47.82
2021-01-01
WBA
Israel leads world in COVID vaccinations per capita
Israel has already immunized about 647,000 people against COVID-19, a whopping 7% of its more than 9.2M residents, according to the Israeli Ministry of Health. In fact, the country has vaccinated more people in the first nine days of its campaign than its total coronavirus infections, which currently stands at 420,000. Bigger picture: "Israel is leading the world. They are vaccinating, on a per capita basis, 15 times faster than the United States," said Dr. Jonathan Reiner, professor of medicine and surgery at George Washington University. "They've already vaccinated 20% of their population over the age of 60. That would be as if we had already vaccinated about 15M Americans over the age of 60." The success in rapidly rolling out doses could hold lessons for countries like the U.S., which has only vaccinated roughly 0.8% of its population against COVID-19 as of Wednesday. Only about 2.8M Americans had received a dose going into the last day of December - far short of the government's target to vaccinate 20M people this month - while 11.2M vials are still sitting on shelves across the country. Operation Warp Speed chief Moncef Slaoui acknowledged last week that the ramp-up of immunizations "is slower than we thought it would be," and U.S. Army Gen. Gustave Perna, who oversees logistics for Operation Warp Speed, repeatedly apologized after some state officials reported cuts to their allocations. The launch of the federal government's partnership with major pharmacy chains like CVS (NYSE:CVS) and Walgreens (NASDAQ:WBA), which will be tasked with vaccinating long-term care residents, is also not fully up and running. Israel's main advantage is its centralized healthcare system, added Eran Segal, a computational biologist at the Weizmann Institute of Science in Rehovot. Israel also has a more simplified insurance system, with just four health maintenance organizations, and it is highly digital, with everyone over age 18 legally required to register with one of the four HMOs. Moreover, Israel is the first country to repackage doses of Pfizer's (NYSE:PFE) vaccine into more easily transportable containers that allow vaccines to move outside of hospitals and into more accessible clinics. Contrast that to the U.S., where most vaccinations are being administered in hospitals or medical centers. Related stocks: Moderna (NASDAQ:MRNA), AstraZeneca (NYSE:AZN), Johnson & Johnson (NYSE:JNJ), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO), Dynavax (NASDAQ:DVAX), GlaxoSmithKline (NYSE:GSK), iBio (NYSEMKT:IBIO), Altimmune (NASDAQ:ALT) and VBI Vaccines (NASDAQ:VBIV). Outlook: With breakthrough technologies, the COVID-19 vaccine pioneers have dominated the year reaching record-breaking market capitalizations as the pandemic wreaked havoc across the globe.
2021-01-02T00:00:00
2021-01-04T00:00:00
38.23
37.849998
37.529999
37.98
38.52
39.07
39
38.009998
38.459999
39.84
42.82
43.41
42.43
41.990002
41.77
41.650002
41.529999
41.48
41.330002
40.439999
40.880001
40.689999
40.669998
39.27
39.869999
39.619999
39.66
39.41
39.34
39.880001
41.400002
41.16
43.029999
45.259998
45.209999
47.700001
47.959999
48.939999
49.32
48.919998
48.150002
48.09
47.07
47.450001
47.82
49.189999
2021-01-01
WBA
Energy and travel among worst S&P 500 performers of 2020
With all the talk about the record year for the markets, some stocks were left out of the rally - especially from the energy and travel sectors - though there were some other surprises. While the S&P 500 rose 16.3% in 2020, these were the top 20 losers on the index: CCL -57%, OXY -56%, NCLH -56%, FTI -55%, MRO -50%, OKE -50%, UAL -49%, HFC -49%, FANG -47%, SLB -46%, VNO -45%, NOV -45%, RCL -45%, WFC -45%, AAL -44%, SPG -44%, APA -43%, XOM -40%, EOG -40%, VLO -39%, COP -38%. The Nasdaq 100 jumped 47.6% in 2020, but here are the 10 worst performers: WBA -32%, FOX -21%, BIIB -18%, INTC -17%, MAR -13%, AEP -12%, SIRI -11%, GILD -11%, CDW -8%, CSCO -7%. The Dow Jones Industrial Average lagged with a 7.2% overall gain, weighed down by BA -34%, WBA -32%, CVX -30%, INTC -16%, MRK -10%, JPM -8%, CSCO -6%, IBM -5%. Hedge fund manager Dan Niles recently listed his top 5 picks for 2021 weighting outside his technology bias, with banking and energy sectors taking the spots.
2021-01-02T00:00:00
2021-01-04T00:00:00
38.23
37.849998
37.529999
37.98
38.52
39.07
39
38.009998
38.459999
39.84
42.82
43.41
42.43
41.990002
41.77
41.650002
41.529999
41.48
41.330002
40.439999
40.880001
40.689999
40.669998
39.27
39.869999
39.619999
39.66
39.41
39.34
39.880001
41.400002
41.16
43.029999
45.259998
45.209999
47.700001
47.959999
48.939999
49.32
48.919998
48.150002
48.09
47.07
47.450001
47.82
49.189999
2021-01-04
WBA
Haven Health Care Venture to disband after 3 years, CNBC says
JPMorgan (NYSE:JPM), Berkshire (NYSE:BRK.A), Amazon (NASDAQ:AMZN) to wind down health care venture after three years, CNBC reported. The companies will continue to collaborate on an informal basis CVS (NYSE:CVS) gained 1.9%; Walgreens (NASDAQ:WBA) rose 3.2% Haven confirmed in May that Atul Gawande was stepping down as CEO of the joint venture The health care joint venture formally announced its name as Haven in March 2019 after being first introduced in January 2018
2021-01-05T00:00:00
2021-01-05T00:00:00
37.849998
37.529999
37.98
38.52
39.07
39
38.009998
38.459999
39.84
42.82
43.41
42.43
41.990002
41.77
41.650002
41.529999
41.48
41.330002
40.439999
40.880001
40.689999
40.669998
39.27
39.869999
39.619999
39.66
39.41
39.34
39.880001
41.400002
41.16
43.029999
45.259998
45.209999
47.700001
47.959999
48.939999
49.32
48.919998
48.150002
48.09
47.07
47.450001
47.82
49.189999
51.18
2021-01-06
WBA
Amerisource Bergen raised at BofA after Walgreen's Alliance deal
AmerisourceBergen (NYSE:ABC) raised to neutral from underpeform at BofA as the deal with Walgreens (NASDAQ:WBA) Alliance helps build on its ``core competency'' through geographic expansion. ``Significant'' EPS contribution, helped by a clean balance sheet and strong cash flow, should ``protect downside'' for ABC Cautions that ``given the magnitude/size of the transaction and some of the challenges that ABC will now inherit with a global business we see less room for upside/growth accretion'' Now sees risk-reward for ABC stock as balanced Earlier, AmerisourceBergen to acquire majority of Walgreens Boots Alliance’s Alliance Healthcare businesses for ~$6.5B, comprised of $6.275B in cash and 2M in ABC common shares. ABC up 7.7% in trading; WBA gained 3%
2021-01-07T00:00:00
2021-01-07T00:00:00
37.98
38.52
39.07
39
38.009998
38.459999
39.84
42.82
43.41
42.43
41.990002
41.77
41.650002
41.529999
41.48
41.330002
40.439999
40.880001
40.689999
40.669998
39.27
39.869999
39.619999
39.66
39.41
39.34
39.880001
41.400002
41.16
43.029999
45.259998
45.209999
47.700001
47.959999
48.939999
49.32
48.919998
48.150002
48.09
47.07
47.450001
47.82
49.189999
51.18
50.68
50.25
2021-01-06
WBA
AmerisourceBergen acquires Walgreens' Alliance Healthcare for $6.5B
AmerisourceBergen (NYSE:ABC) to acquire majority of Walgreens Boots Alliance’s (NASDAQ:WBA) Alliance Healthcare businesses for ~$6.5B, comprised of $6.275B in cash and 2M in ABC common shares. The transaction is expected to close by the end of AmerisourceBergen’s 2021 fiscal year. For Walgreens, the deal means it will be able to increase focus on expanding its core retail pharmacy businesses, bringing even greater healthcare offerings to patients and customers and further accelerating its progress on its clear set of strategic priorities. In addition to the acquisition, both the companies have agreed to extend and expand U.S. commercial agreements through 2029 to drive incremental growth. The acquisition of Alliance Healthcare is expected to deliver high-teens percentage accretion to ABC's adjusted diluted EPS in the first fiscal year. The company expects synergies from the acquisition to ramp to an annual run-rate of $75M in Q4. Adjusted free cash flow of the combined AmerisourceBergen and Alliance Healthcare businesses are expected to increase to 125% of AmerisourceBergen's stand-alone estimates. Walgreens Boots Alliance expects FY21 adjusted EBITDA to be in the range of $575M-$580M for these Alliance Healthcare businesses. AmerisourceBergen will host a conference call today at 8:30 a.m. ET. ABC +6%, WBA +2% premarket. In other news, ABC boosted FY21 EPS guidance, with the increase excluding any contribution from the Alliance Healthcare deal.
2021-01-07T00:00:00
2021-01-07T00:00:00
37.98
38.52
39.07
39
38.009998
38.459999
39.84
42.82
43.41
42.43
41.990002
41.77
41.650002
41.529999
41.48
41.330002
40.439999
40.880001
40.689999
40.669998
39.27
39.869999
39.619999
39.66
39.41
39.34
39.880001
41.400002
41.16
43.029999
45.259998
45.209999
47.700001
47.959999
48.939999
49.32
48.919998
48.150002
48.09
47.07
47.450001
47.82
49.189999
51.18
50.68
50.25
2021-01-07
WBA
Walgreens rides cost management efforts to earnings topper
Walgreens Boots Alliance (NASDAQ:WBA) trades 3.25% higher after sliding past FQ1 estimates. Bank of America says Walgreens a strong FY1Q beat, as better international performance and strong cost management across the enterprise led to it topping revenue, EPS and EBIT expectations. "This is despite US Retail revenue SSS metrics that mostly missed our expectations, offset in this segment by better GM pull-through, with management pointing to better procurement savings and higher front-end gross margin. Even with this strong beat management maintained full year guidance, noting ongoing headwinds from softer cough/cold/flu, COVID-related lockdowns, and incremental growth investments," notes the firm. Walgreens maintained FY21 guidance of low single-digit growth from $4.74 vs. $4.81 consensus.
2021-01-08T00:00:00
2021-01-08T00:00:00
38.52
39.07
39
38.009998
38.459999
39.84
42.82
43.41
42.43
41.990002
41.77
41.650002
41.529999
41.48
41.330002
40.439999
40.880001
40.689999
40.669998
39.27
39.869999
39.619999
39.66
39.41
39.34
39.880001
41.400002
41.16
43.029999
45.259998
45.209999
47.700001
47.959999
48.939999
49.32
48.919998
48.150002
48.09
47.07
47.450001
47.82
49.189999
51.18
50.68
50.25
48.830002
2021-01-07
WBA
Walgreens Boots EPS beats by $0.18, beats on revenue
Walgreens Boots (NASDAQ:WBA): Q1 Non-GAAP EPS of $1.22 beats by $0.18; GAAP EPS of -$0.36 misses by $1.16. Revenue of $36.3B (+5.7% Y/Y) beats by $1.29B. Company maintained guidance of low single-digit growth in adjusted earnings per share at constant currency rates. Gross margin of 19.8% vs. 19.7%, Operating margin of 3.3 % vs. 3.3% consensus. Amerisource Bergen raised at BofA after Walgreen's Alliance deal. Shares +2.4% PM. Press Release
2021-01-08T00:00:00
2021-01-08T00:00:00
38.52
39.07
39
38.009998
38.459999
39.84
42.82
43.41
42.43
41.990002
41.77
41.650002
41.529999
41.48
41.330002
40.439999
40.880001
40.689999
40.669998
39.27
39.869999
39.619999
39.66
39.41
39.34
39.880001
41.400002
41.16
43.029999
45.259998
45.209999
47.700001
47.959999
48.939999
49.32
48.919998
48.150002
48.09
47.07
47.450001
47.82
49.189999
51.18
50.68
50.25
48.830002